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Electrochemical studies were performed to explore electron transfer (ET) between human white 
blood cells (WBC) and carbon fiber electrodes (CFE). Currently, an active area of research 
involves encouraging ET between microbes and various electrodes in a biofuel cell (BFC). ET 
between microbes and electrodes are thought to occur i) directly through plasma membrane-
bound electron transport chain proteins; and/or ii) indirectly through the release of metabolic 
products or biomolecules near the electrode surface. An important motivation of this research is 
the need for alternative long lasting power sources for implantable diagnostic and therapeutic 
devices. A particular interest is reducing the size and weight of implantable devices. Currently 
employed internal batteries largely contribute to both. BFCs are promising prospects as they 
couple the oxidation of a biofuel (such as glucose) to the reduction of molecular oxygen to water. 
Both glucose and oxygen are abundantly present within our body’s cells and tissues. The goal of 
this project is to explore the feasibility of utilizing WBCs (a human cell model) to generate 
electricity by fostering direct or indirect ET between these cells - or more specifically, between 
the metabolic processes of these cells - and the anode of a BFC. ET from the metabolic processes 
of whole cells to electrodes had, to the best of our knowledge, only previously been 
demonstrated for microbes. The electrochemical activities of WBCs isolated from whole human 
blood by red blood cell (RBC) lysis, peripheral blood mononuclear cells (PBMCs) isolated on a 
Ficoll-Paque gradient, as well as cells from a BLCL cell line and two leukemia cell lines (K562 
 iv 
and Jurkat) were all investigated by incorporation of the cells into the anode compartment of a 
proton exchange membrane fuel cell (PEMFC). Cyclic voltammetry was employed as an 
electrochemical technique to investigate the ET ability of the cells, as it can reveal both 
thermodynamic and kinetic information regarding oxidation-reduction processes at the CFE 
surface. The results of our studies demonstrate that upon activation, biochemical species, such as 
serotonin, are released by PBMCs, which may become irreversibly oxidized at the electrode 
surface.   
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1.0 INTRODUCTION 
Energy delivery to implantable medical devices has for many years been faced with a 
myriad of hurdles. The primary problem is that once the device is implanted within the body, it 
becomes a difficult task to make any necessary adjustments to the device, such as replacing its 
power source. A list of implantable devices for electrical stimulation and their operating 
parameters is shown in Table 1 [1]. One of the most reliable power sources for any electronic 
device is the lithium ion battery that must be replaced once its fuel content has been expended. 
Despite the fact that significant improvements have been made and continue to be made in 
extending the lifetime of these batteries, replacement at some point in time would still become 
necessary. Replacing the internal battery of an implanted device is largely undesirable, 
particularly from the patient’s perspective, since this inevitably requires surgical intervention. 
Rechargeable batteries have also been pursued, which would require the patient to be largely 
responsible for the recharging process. Recharging would be achieved through various methods 
of transcutaneous power delivery such as radiofrequency or optical methods. However, in 
placing this responsibility in the hands of the patient, compliance becomes a major problem [2].  
The primary objective of this study is to investigate the concept of developing an 
implantable power supply which mimics the body’s ability to metabolize organic substrates. The 
goal would be to develop a device that would be capable of transducing the biochemical energy 
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stores within the body into electrical energy. Previous research in this area was met with failure 
mostly related to biocompatibility issues, encapsulation of the device and decline in performance 
with time [3]. At that time, little was known about the reactions taking place at the electrode 
surface. There were also problems related to inefficiency of the electrode reactions due to mixed 
reaction kinetics [3] with the insertion of the anode and cathode into a homogenous environment. 
The hope is that the present work, which focuses on biofuel cell technologies, will further 
revitalize an interest in using these technologies to power implantable devices, particularly 
devices that require lower power densities as we move into an era of micro- and nano-
technologies.  
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Table 1: Clinical stimulation parameters for some implantable medical devices [1].  
 
APPLICATION METHOD OF 
STIMULATION 
DELIVERY 
WAVEFORM/DURATION 
OF STIMULATION 
CURRENT/VOLTAGE 
REQUIREMENTS 
Cardiac Pacing Electrodes in 
contact with the 
heart. Electrode 
impedances 
between 250 and 
1000 Ω. 
Capacitor discharge pulse 
between 0.1 and 2ms 
duration, with charge 
balancing phase.  
0.1 to 8V peak  
Pain Relief Electrodes in 
contact with 
spinal cord. Can 
also be in contact 
with the targeted 
peripheral nerve 
associated with 
the pain. 
Either monophasic or 
biphasic pulses of approx. 
210 µs duration. Delivered at 
frequencies between 30 and 
80 Hz.  
0.1 to 12 V peak 
Deep Brain 
Stimulation 
Electrodes 
implanted in the 
brain at regions 
responsible for the 
control of 
movement. 
Electrode 
impedances: 600 
to 2000 Ω. 
60 to 450 µs charge-balanced 
capacitor discharge pulses 
delivered at 2 to 185 Hz.  
0.1 to 10.5 V 
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2.0 BACKGROUND 
2.1 CHALLENGES IN ENERGY DELIVERY TO IMPLANTABLE DEVICES 
 
In order to effectively tackle the problem of energy delivery to implantable devices, it is 
important to consider two facets of the problem: 1) the power source (an energy transduction 
device that converts energy from one form, such as chemical, to a more useful form, such as 
electricity); and 2) the transmission modality (method of transferring energy from an external 
power source to the target device). Several types of power sources have been investigated for use 
with implantable devices, including batteries [4, 5], nuclear/thermoelectric batteries [6, 7], 
piezoelectric devices [8, 9], and biological/biochemical fuel cells [3, 10]. In instances where the 
power source is located extracorporeally, transcutaneous energy transmission modalities 
including radiofrequency links/magnetic transcutaneous coupling [11], optical methods [5], 
ultrasound [12], and volume conduction [13, 14] have been proposed.  
Each method has its own drawbacks, usually with respect to insufficient power levels 
(optical, ultrasound), decline in performance with time (batteries, implantable biochemical fuel 
cells), and intractability for patient use and maintenance (magnetic transcutaneous inductive 
coupling devices). As an illustrative example of progress in the development of implantable 
power sources, consider the cardiac pacemaker. The pacemaker may be considered one of the 
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most successful implantable devices ever built. Substantial effort has been placed into the design 
of the device, including the development of its power source. It was noted in one early journal 
article that by 1970, the average pacemaker was explanted in less than 2 years, 80% of those 
explanted having experienced some form of battery failure [15]. Zinc-mercury, nuclear and 
lithium batteries have all been used, but today lithium ion batteries are most commonly 
employed. With the lithium ion batteries, a service life of more than 10 years can now be 
expected [16]. Taking the above example of the cardiac pacemaker, it is crucial - both to the 
success of the device and the health of the patient - to develop a continuous, efficient, and low-
maintenance energy supply with sufficiently high power output and longterm electrical stability 
for implantable devices. The power source should pose minimal threat to the health of the 
patient, and should not compromise the functionality of the device. With the current trend of 
improvements in biomaterials and biocompatibility, biosensor and biofuel cell technologies, and 
with the miniaturization of devices (micro- and nano-technologies) that demonstrate ever 
decreasing power requirements, biological power sources hold some promise for future 
implantable medical device applications. The utilization of biochemical energy resources in the 
body will become particularly important as we look toward miniature devices, where a lithium 
ion battery would become impractical due to constraints on size and weight.  
 5 
  
2.2 POWER SOURCES 
2.2.1 Internal Batteries 
The main disadvantage of current internal batteries is that the duration of the power supply is 
often limited by the battery capacity, that is, limited by the quantity or concentration of the 
available reactants [4]. The energy generated by the battery is based on electrochemical 
reactions, which eventually go to completion after some time. Once the potential and current 
levels have diminished to a point where the battery is unusable, replacement of the battery 
becomes necessary. When speaking about a device that is implanted within the human body, the 
issue of replacement can be rather complicated. Surgical intervention is the only option to 
replace an internal battery that has either failed or reached the end of its lifetime. Multiple 
surgical interventions are costly, can be painful and are truly inconvenient for any patient. In the 
case of a deep brain stimulator, an average battery life of 4-5 years can be expected for typical 
settings, which can easily drop to 1-2 years if programming of the device is suboptimal [17]. 
Although the procedure for replacing the pulse generator is relatively simple, that is, an 
outpatient surgery with a small incision in close proximity to the device, there could be the 
detrimental effects of scarring and infection. In addition, the procedure itself is rather costly, in 
the vicinity of $10,000 [17].  
In order to ensure that the length of time between surgeries is maximized, battery 
designers and developers have worked to increase the capacity and life expectancy of the 
batteries, without compromising weight and size. The smaller and lighter the battery, obviously 
the better. Internal batteries can be bulky, reflecting the fact that they must carry their energy 
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stores. Lithium batteries are most commonly used today and have had tremendous success, 
largely due to the fact that they are lighter and have a greater energy and power capacity than 
other batteries, such as the zinc-mercury batteries that were previously used. A lithium battery 
develops a voltage of 2.8V, which can be stepped up to 5V or higher using circuitry [16]. This 
was a great improvement over its predecessor, the zinc-mercury battery, which had an 
operational voltage of 1.35V. Depending on the pacemaker, 3 to 5 zinc-mercury batteries were 
needed. In addition to the drawback with respect to size, these batteries were often prone to 
failure within a very short time period, normally within two years [15]. The invention and 
application of lithium ion batteries greatly impacted the implantable medical device field. The 
lifetime of cardiac pacemakers was significantly increased, no gas was evolved by the battery 
(electrochemical cell could be hermetically sealed) unlike its predecessor, and it had an electric 
charge capacity of 4.14Ah, with a service life of more than 10 years [16]. By 1980, they powered 
over 95% of the world’s pacemakers [15]. 
2.2.2 Nuclear Batteries 
In the 1970s, the use of plutonium 238 appeared to be promising as a power source, particularly 
for cardiac pacemakers [7]. High velocity alpha particles emitted by plutonium during nuclear 
decay would bombard the container’s wall generating heat. The heat would traverse the wall and 
subsequently be converted to electrical energy by thermopiles. The half-life of plutonium (Pu) is 
87 years [16]. It was, therefore, capable of providing an almost limitless power supply to 
implantable electronic devices, such as the cardiac pacemaker. Nuclear batteries were introduced 
into cardiac pacemakers, which were then implanted into patients. Due to regulatory problems 
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concerning the control of the nuclear fuel, however, the total number of nuclear pacemakers 
never exceeded 1% of total pacemakers implanted annually [2]. Although safety really was not 
the primary issue, there was still some concern about the toxicity of the fuel (one microgram of 
plutonium 238 in the blood stream could be fatal). The real concern, however, was the 
exceedingly long half-life of the radioisotope, which made it difficult for its universal 
acceptance. Questions arose regarding the best way to keep track of the nuclear powered 
pacemakers. A lost nuclear powered pacemaker can still pose a threat to future generations 
hundreds of years later. From a purely technological perspective, the Pu 238 nuclear pacemaker 
was shown to be the most reliable pacing system every built. Between 1970 and 1975, nearly 
1400 nuclear pacemakers were implanted without a single battery failure [6].  
2.2.3 Piezoelectric Devices 
Piezoelectric power sources convert kinetic or mechanical energy into electrical energy [8, 9, 
18]. These often, however, do not produce sufficiently large current or power densities for 
implantable medical device applications. Recently, however, researchers at the Georgia Institute 
of Technology (Atlanta, GA) developed a prototype nanometer scale generator that produces 
continuous direct current by harvesting energy from environmental sources such as ultrasound, 
mechanical vibrations and blood flow [18]. The device was based on vertically aligned zinc 
oxide nanowires that generate small electrical charges when bent. This piezoelectric device was 
particularly attractive because zinc oxide has been deemed non-toxic and biocompatible. 
However, from a technical standpoint, it is difficult to identify a suitable mechanical energy 
source within the body.    
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2.2.4 Biological Power Sources 
Biofuel and biogalvanic cells have been investigated in the past [3, 10]. In one study by Drake et 
al. (1970) [3], the authors were able to achieve an open circuit potential of 650mV, maximum 
power density of 3.5 µWcm-2 and maximum current density of 8.3 µAcm-2 from an in-vivo 
implanted biochemical fuel cell. There were significant problems, however, with the system. One 
problem was the fact that the electrochemical cells (EC) eventually appeared to become 
permanently electrically insulated from the tissue environment, thus becoming inoperative. 
Protein adsorption on the electrode surface and host fibrotic response and encapsulation were 
observed. The authors also noted that the near neutral pH and low buffering capacity of the 
interstitial fluid reduced the electrode performance, with polarization of the cathode occurring 
due to the formation of hydroxide ions. Electrode poisoning was also an issue due to parasitic 
reactions and increased polarization that occurred as a result of mixed reaction kinetics. It should 
be noted that the biochemical fuel cell must be placed within a very homogenous environment, 
where both electrodes are simultaneously exposed to the same reactants and conditions. The 
homogeneity of the tissue environment is reflected in decreased performance of the biochemical 
fuel cells in-vivo due to fuel crossover or non-specificity of the reactions taking place at the 
electrodes. An interest in the clinical application of biochemical or biogalvanic fuel cells quickly 
faded. In an attempt to solve the problems related to the implantation of biofuel cells into 
homogenous environments, the development of enzyme-based biofuel cells has been actively 
pursued [19-21]. With the immobilization of enzymes at the anode and cathode, electrode 
specific reactions are encouraged, thereby reducing the problems associated with mixed reaction 
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kinetics.  A more in depth description and discussion of enzyme-based biofuel cells will be 
presented in a later section (Section 3.3). 
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2.3 TRANSCUTANEOUS ENERGY TRANSMISSION 
Radiofrequency [11, 22, 23], ultrasound [12], and optical (infrared) methods [5] have all been 
studied as possible means of delivering power transcutaneously to implanted medical devices or 
to internal rechargeable batteries used to power such devices. Transcutaneous energy 
transmission obviates the need for wire leads that penetrate the skin, thus removing the 
possibility of infections associated with sites of wire entry through the skin. Despite the high 
efficiency associated with the commonly used RF transmission (up to 95% [11]) RF may be 
associated with unwanted heating and tissue damage [24]. Ultrasound and optical methods, 
though attractive as non-invasive energy transmission modalities, have the disadvantage of 
quickly becoming attenuated through the skin. In addition, optical methods such as infrared can 
also be associated with unwanted heating [25].  
The use of transcutaneous energy transmission modalities for powering implantable devices 
never really gained as much momentum as would have been expected. They provide a relatively 
simple approach for dealing with power issues with respect to implantable devices, because they 
could easily be applied to the recharging of an implanted secondary battery. In the past, 
rechargeable batteries have been used to power cardiac pacemakers [26]. A nickel-cadmium 
battery was developed with a 120mAh capacity. Transcutaneous recharging using two-way 
telemetry (magnetic coupling) was a feature of the system and more than 6000 units were 
implanted between 1973 and 1978 [2]. However, the drawback was that the patient was 
responsible for ensuring that the unit was recharged, which led to compliance problems. Despite 
the fact that the system was technologically successful and reliable, the subsequent development 
of Li-ion batteries made it obsolete.  
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3.0 BIOFUEL CELLS: A REVIEW 
This section provides a brief overview of biofuel cell technologies that have been developed over 
the past several years. Enzyme-based and microbial-based biofuel cells are highlighted and 
historical milestones described. Microbial fuel cells have recently attracted a lot of attention due 
to their potential applications as alternative renewable energy sources (producing electricity from 
waste water treatment [27]). The idea of using bacteria to convert chemical energy stored in 
waste water sewage into electrical energy to power our homes and businesses is an attractive 
concept. Progress in the area of enzyme-based biofuel cells have also been accelerated due to 
potential medical applications, particularly as self-powered biosensors. Such biofuel cells take a 
biomimetic approach to solving the energy delivery problem in the body, seeking to imitate the 
biochemical processes involved in glucose metabolism. The goal of this section is to provide a 
general introduction to biofuel cell technologies and to examine their potential applications in the 
field of medicine as in-vivo energy delivery devices.   
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3.1 INTRODUCTION TO BIOFUEL CELLS 
With recent governmental initiatives to fund research in alternative energy sources, significant 
work has been performed in studying and developing biofuel cell technologies, particularly 
studies related to electricity generation from microbial fuel cells, as well as enzyme-based 
biofuel cells. There appears to be a renewed interest in this field, particularly in the area of 
microbial fuel cells (MFCs). The ability of microbes to metabolize a vast range of organic 
substrates as well as their evident ability to transfer high energy electrons derived from their 
metabolic processes to electrode surfaces have sparked an interest in utilizing microbes to 
generate electricity from organic fuels and even waste water effluent. The microbes would 
essentially serve as miniature bioreactors, breaking down organic substrates (such as glucose, 
lactate, acetate) into carbon dioxide, while liberating electrons derived from the catabolism of the 
fuels to an electrode in close proximity. This process of electron transfer between the cell and 
electrode, is perhaps the most important and challenging aspect in the development of efficient 
biofuel cell systems or any bioelectronic system. Much of the work involved in optimizing the 
current and power output of biofuel cells is associated with increasing the electron transfer 
efficiency, not only between whole cells and electrodes, but between enzymes and electrodes as 
well.   
Biological fuel cells or biofuel cells (BFC) are energy transduction devices that convert 
the chemical energy stored in organic substrates into electrical energy. In order to access the 
energy from these substrates, enzymes as well as whole cells, particularly microbial organisms, 
have been used [27-40]. BFCs function by coupling two reactions, the oxidation of a biofuel (by 
microbes or enzymes) at the anode and the reduction of molecular oxygen to water at the 
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cathode. High energy electrons derived from the oxidation of glucose, for example, can be 
transferred from the metabolic processes of various types of bacteria, such as Escherichia Coli 
[27, 34, 35, 40], or from the redox centers of immobilized enzymes, such as glucose oxidase [19-
21], to an electrode. The electrons travel from the anode to the cathode of the BFC, where they 
are finally accepted by molecular oxygen. Protons released at the anode during the oxidation of 
the glucose fuel traverse the electrolyte volume - and perhaps also a proton exchange membrane 
(PEM) separating the two electrodes in the case of MFCs - into the cathode compartment. The 
availability of electrons and protons at the cathode foster the reduction of molecular oxygen to 
water. For an efficient system, the only byproducts of a BFC should be carbon dioxide and 
water. This is an attractive feature of BFCs since the byproducts are non-toxic. BFCs would, 
therefore, be more environmentally friendly, compared to other electrochemical cells such as 
lithium-ion or zinc mercury batteries.  
Fuel cells (FC), in general, are unique in that they are capable of producing electricity as 
long as there is a continuous supply of chemical reactants [41, 42]. Batteries, however, 
eventually lack sufficient quantities of reactants necessary to maintain the desired potential and 
power output [16]. The working voltage produced by a single cell normally lies between 0.5 and 
0.8V [41]. For a hydrogen fuel cell (see Figure 1), the theoretical maximum potential is 1.23V, 
which corresponds to the standard reduction potentials for the reaction between hydrogen and 
oxygen to form water. They are generally much more efficient than other energy conversion 
devices, such as internal combustion engines, which rely on the expansion of gases to do work. 
The proton exchange membrane (PEM), often used to separate the anode from the cathode 
compartment in low temperature PEM fuel cells, comprises long chains of 
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polytetrafluoroethylene (PTFE), commonly known as Teflon, with the side chain ending with 
sulphonic acid (HSO3) [41].  
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Figure 1: A Hydrogen Fuel Cell 
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3.2 MICROBIAL FUEL CELLS 
Microbial Fuel Cells (MFC) employ bacteria such as Escherichia Coli [27, 34, 35, 40], Rhodoferax 
ferrireducens [31], Geobacter sulfurreducens [30], Saccharomyces Cerevisiae [43] among others to generate 
electricity by coupling electron transfer between the cells and the anode electrode to oxygen reduction at the 
cathode (Figure 2). A mixed bacterial population may also be used [29, 37, 38, 44, 45]. Artificial electron 
mediators were often introduced to the anode chamber in an effort to increase the efficiency of electron 
transfer. In several MFC studies, it was reported that electron transfer occurred only at very low efficiencies 
between the cells and electrodes [46]. One such mediator, methylene blue (labeled MB in Figure 2) has been 
used by researchers [43] to shuttle electrons between the metabolic processes of the micro-organisms and the 
anode. Other researchers have succeeded in immobilizing artificial electron mediators such as neutral red 
(NR) onto the electrode surface, leading to improved electron transfer efficiencies, and higher current and 
power densities [34]. In a study by Park et al. (2000), a MFC was designed with E. Coli as the bacteria and 
acetate as the organic substrate [34]. NR was immobilized using N,N’-dicyclohexylcarbodiimide, which can 
induce the formation of peptide bonds between the amine of NR and carboxy group of the graphite anode. 
The current density obtained from the MFC with immobilized NR was 3.1µAcm-2, compared to a current 
density of 1.41µAcm-2 for the MFC with a native (unmodified) graphite anode. Apart from the 
immobilization of artificial electron mediators on the surface of graphite or other carbon-based electrodes, 
other electrode modification methods have been developed, such as the overlaying of conductive polymers 
[40] and the attachment of the transition metal Mn [35].  
Table 2: Summary of some Microbial Fuel Cell studies.  
 
 provides a summary of previous MFC studies by various research groups. In an ideal system, the 
reactions that would be expected at the anode and cathode of a biofuel cell would be as follows: 
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The catalysis of glucose to carbon dioxide would be facilitated by the bacterial species or 
enzyme at the anode. Electron transfer would occur either through the release of metabolic 
species or through a direct electrical communication between the electron transport proteins in 
the cell membrane and the electrode. Artificial electron mediators, as described previously, 
would also act to shuttle electrons between the intracellular metabolic processes and the 
electrode surface. At the cathode, in order to increase the efficiency of electron transfer to 
oxygen, potassium ferricyanide is used. Ferricyanide has a very high electron affinity and can be 
coupled to oxygen reduction as it changes between its reduced state ( ) and its oxidized 
state ( ). Protons liberated during glucose catabolism traverse the electrolyte and/or 
PEM to take part in the oxygen reduction reaction at the cathode.  
−4
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Figure 2: A Microbial Fuel Cell. Methylene blue (MB) is an electron mediator commonly used to increase the 
efficiency of electron transfer between the whole cells and the electrode surface. 
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Table 2: Summary of some Microbial Fuel Cell studies.  
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The applicability of MFCs has been limited due to a number of factors, including: 1) the 
frequent need to introduce artificial electron mediators at the anode; 2) the lack of long term 
stability of the electrodes (electrode fouling); and 3) incomplete oxidation of the biofuel used by 
the microbes [47]. The current output of the MFC may be limited by: 1) the rate of metabolism 
of the biofuel by the microbial population; 2) the number of electrons transferred (electron 
efficiency) and 3) the rate of electron transfer (which for many cases depends on the electron 
carrying ability of the electron mediators).  
 
Microorganisms 
Microorganisms used in MFCs may be divided primarily into three groups: 1) organisms that 
directly transfer electrons through membrane-bound proteins; 2) organisms that transfer electrons 
through the release of metabolic products; 3) organisms that require the intervention of artificial 
electron mediators to effectuate electron transfer. Earlier studies investigating the unique ability 
of microbes to effectuate electron transfer between their metabolic processes and electrodes 
indicated that this electron transfer ability could only occur at very low efficiencies [39]. As a 
result, artificial electron mediators were introduced that could penetrate the plasma membranes 
of the cells, to interact directly with their metabolic processes. The dual nature of the electron 
mediators (both hydrophobic and hydrophilic characteristics) permitted them to move effectively 
between the aqueous phase of the extracellular solution and the lipid phase of the cell membrane. 
Several electron mediators have been utilized with a diverse range of bacterial species. As 
interest in MFCs has grown, it has been found that certain bacteria are capable of effectuating 
direct electron transfer at much higher levels of efficiency than observed before [29, 30, 36, 37, 
47].  One such type of bacteria is Geobacter sulfurreducens [30]. Members of the 
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Geobacteraceae family have been shown to be capable of transferring electrons to insoluble 
electron acceptors such as Fe (III) oxides. Bacteria belonging to this family are not known to 
produce any soluble electron mediators themselves [48], and therefore, it has been hypothesized 
that they are able to directly transfer electrons to an electrode surface. In a study by Bond et al., it 
was shown that 1) G. sulfurreducens can completely oxidize electron donors, using electrodes as 
the final electron acceptor; 2) electron transfer can occur to electrodes in the absence of electron 
mediators; 3) electron transfer was due to a population of microbes attached to the electrode that 
are capable of rates of electron transport similar to those observed for electron transport to 
Fe(III) citrate [30].  
 
Electrode Design 
Various types of electrodes have been designed in an attempt to maximize the current and power 
output available from MFCs. The difficulty that electrode modifications seek to overcome is the 
generally low efficiency in electron transfer that normally occurs between the redox active 
centers in the plasma membranes of the microbes and the electrode surface. The distance 
between the electrode surface and the redox active species in the cell membrane impacts greatly 
on electron tunneling between the donor and acceptor. As a result, researchers have 
experimented with novel ways by which improved electron transfer efficiencies can be achieved. 
In one study by Schroeder et al. (2003) [40], a novel electrode was described that was 
constructed from carbon cloth modified by application of a platinum black layer and covered by 
an electrocatalytic conductive polymer (polyaniline). With this novel electrode, as well as with 
the application of periodic regenerative potentials to the electrode surface, the researchers were 
able to acquire current densities as high as 1.5mAcm-2, 9mW power output and a cell potential of 
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469mV from their MFC. The bacterial population used in the study consisted of Escherichia Coli 
K12. The authors hypothesized that the conductive polymers contributed extensively to the high 
current and power densities, by fulfilling a multitude of tasks including: i) functioning as a redox 
mediator, by interacting with the redox centers of the bacteria; ii) becoming involved in the 
oxidation of metabolites released by the bacteria; iii) serving as a barrier to large molecules that 
would otherwise contribute to electrode fouling.  
 
Electron Mediators 
The usual means of improving electron transfer efficiencies was through the use of artificial 
electron mediators, including methylene blue [43], neutral red [27, 34] and 2-hydroxy-1,4-
naphthoquinone (HNQ)  [28]. There are, however, problems associated with the use of such 
mediators.  Roller et al. (1984) [39] outlined some conditions for efficient MFCs employing 
electron mediators:  
1) the microorganism should be able to rapidly reduce the mediator 
2) rapid oxidation of the mediator at the MFC electrode 
3) the redox potential of the mediator should be highly negative, in order to achieve the 
maximum potential difference between anode and cathode, while still being able to 
couple with the microbial metabolism 
4) the mediators should be both relatively stable  and soluble in aqueous systems.  
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3.3 ENZYME-BASED BIOFUEL CELLS 
Enzyme-based biofuel cells (enzBFC) have been studied extensively [19-21, 49], particularly for 
possible applications as in-vivo power sources. These BFCs involve the immobilization of 
specific enzymes onto various electrode (such as carbon fiber) surfaces (Figure 3). Glucose 
oxidase (GOx) is the primary enzyme employed at the anode. It catalyzes the oxidation of 
glucose to gluconolactone. At the cathode, either the enzymes laccase [21] or bilirubin oxidase 
(BOD) [19] have been used to facilitate the reduction of molecular oxygen to water. The 
enzymes are immobilized by polymer tethers that link the redox active sites of the enzymes to 
the electrode surface. Mano et al. (2003) developed a miniature compartment-less biofuel cell 
that was shown to be capable of generating small electrical currents within a living grape [19].  
The polymer used for BOD wiring at the cathode was (PAA-PVI-[Os(4,4’-dichloro-2,2’-
bipyridine)2Cl]+/2+) and that used for GOx wiring at the anode was (PVP-[Os(N.N’-dialkylated-
2,2’-biimidazole)3]2+/3+). The authors reported that the miniature BFC was capable of generating 
a power output of 2.4 µW and 0.52 V potential.  
 
Eliminating the proton exchange membrane 
The direct wiring of enzymes to electrode surfaces has a number of advantages with respect to 
BFC systems, including improved efficiency in electron transfer and obviation of a proton 
exchange membrane to separate the anode and cathode compartments. Using dissolved electron 
mediators to shuttle electrons between the enzymes and the electrodes made the PEM necessary 
in order to prevent electroxidation of the anode mediator at the cathode and reduction of the 
cathode mediator at the anode [50-52]. The PEM was also necessary to prevent the occurrence of 
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fuel crossover, where electrons from the organic substrate would be transferred directly to 
oxygen, rather than to the electrode, the desired electron acceptor. In such an instance, there 
would be a very low incidence of electron transfer to the electrode, resulting in small current and 
power densities. Modification of the electrode surface with enzymes contributed to greater 
specificity in the reactions that occurred at each electrode. A summary of recent work performed 
in the field of enzyme-based biofuel cells can be found in Table 3. 
 
Electrical communication between enzymes and electrodes 
The lack of electrical communication between enzymes and electronic elements has been 
identified as a fundamental difficulty in the development of bioelectronic systems [53]. This 
challenge can be explained by: 1) Marcus theory; 2) superexchange charge transfer theory; and 
3) superior tunneling paths in proteins. In order to overcome this difficulty, a number of methods 
have been employed to improve the efficiency of electron transfer: 1) structural engineering of 
proteins with electron relays; 2) immobilization of redox enzymes in conductive polymers or 
redox active polymers; and 3) steric alignment of proteins on electron relays associated with 
electrodes [53].   
 . 
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Figure 3: An Enzyme-based Biofuel Cell 
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Table 3: Summary of some research studies on Enzyme-based Biofuel Cells. 
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4.0 NADPH OXIDASE 
Electron transport through NADPH oxidase 
Electron transport is generally not observed across the plasma membrane of eukaryotic cells. 
However, recent data demonstrates that such electron currents do exist in white blood cells [54-
57]. Schrenzel et al. (1998) demonstrated that small currents can be measured across the plasma 
membrane of human eosinophil granulocytes [57]. The experiments were performed based on 
the hypothesis that the membrane associated enzyme NADPH oxidase, found in blood 
phagocytes, generates reactive oxygen species (ROS) through electron transfer from NADPH to 
extracellular oxygen (Figure 4). The magnitudes of the currents recorded across the cellular 
membranes were on the order of 10 to 20 pA per cell. NADPH oxidase is a complex of several 
proteins that associate with each other when activated [54, 58, 59]. Activation in vitro was 
achieved by application of phorbol-12-myristate-13-acetate (PMA) [55-57]. PMA most likely 
activates NADPH oxidase through the protein kinase C (PKC) pathway [58]. NADPH oxidase 
has also been found in microglia [60], vascular smooth muscle [61], endothelial cells [62] and 
hematopoietic stem cells [63]. The presence of an electron transport chain in the plasma 
membranes of white blood cells and glia means that it may be possible for electrons to be 
”hijacked” and diverted to a nearby electrode, such as was observed in the case of microbial fuel 
cells. Interactions between the cells and the electrode surface become important. The surface of 
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the electrodes may be modified to improve these interactions, and facilitate the electron transfer 
process. Electron mediators such as methylene blue and neutral red may not be ideal due to the 
potential for toxicity with time.  
 
Structure of NADPH Oxidase 
NADPH oxidase consists of five primary components, namely p40PHOX, p47PHOX, p67PHOX, 
p22PHOX, gp91PHOX (PHOX for PHagocyte OXidase). Three of the five components - p40PHOX, 
p47PHOX and p67PHOX - exist as a complex in the cytosol of resting cells. The other two are 
primarily located in the membranes of secretory vesicles and specific granules. These two 
components occur as a heterodimeric flavohemoprotein known as cytochrome b558 [64]. A sixth 
cytosolic component has also been identified, namely Rac, which belongs to the Rho-subfamily 
of small GTPases [58]. Upon activation, the components of NADPH oxidase are transferred to 
the plasma membrane of the cell through vesicular fusion. Reactive oxygen species produced by 
activated NADPH oxidase of phagocytic cells play a key role in immune responses to pathogens. 
Life-threatening conditions, such as chronic granulomatous disease (CGD) result from genetic 
defects that target NADPH oxidase, compromising its function and ability to produce ROS. 
However, uncontrolled production of ROS has been associated with tissue damage and several 
diseases. 
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Figure 4: White blood cell NADPH oxidase activity during respiratory burst. 
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NADPH Oxidase and Disease 
Several studies have linked NADPH oxidase to various diseases and disease states including 
Parkinson’s [60], Alzheimer’s [65], oxidative damage resulting from epileptic seizures [66] and 
hypoxic pulmonary vasoconstriction [67]. The pentose phosphate pathway (PPP) and NADPH 
oxidase activity are normally very tightly regulated to ensure that there is minimal or no damage 
resulting from the overproduction of reactive oxygen species (ROS) in the physiological 
environment. In certain circumstances, however, this regulated balance in ROS can be 
compromised, and the NADPH oxidase complex can become overactive, either leading to or 
exacerbating pathological conditions, such as those previously described.  
 
Electrical communication between NADPH oxidase and electrodes? 
In order for ROS to form, high energy electrons from the PPP of glucose metabolism must be 
transferred to oxygen. In this case, it might be possible to channel some of those electrons to an 
electrode and through an electric circuit (Figure 5), powering implanted devices. The most 
fundamental problem to tackle is, therefore, promoting the transfer of metabolically derived 
electrons to interfacing, biocompatible, implanted electrodes. For certain neurological disorders 
where NADPH oxidase has been shown to be overactive, electrons could be harnessed from the 
metabolism of the associated cells to power a drug delivery device. This device would have 
special target drugs that can then be used to suppress an epileptic seizure or slow the progress of 
neurodegenerative disorders including Parkinson’s and Alzheimer’s disease.  
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Figure 5: A theoretical eukaryotic cell-based biofuel cell that relies on electronic coupling between 
NADPH oxidase and a carbon-based electrode. 
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5.0 LEUKOCYTE-BASED BIOFUEL CELL STUDY 
5.1 ABSTRACT 
The electrochemical activity of human leukocytes (white blood cells) was investigated by 
measuring the current output and open circuit potential produced from a proton exchange 
membrane fuel cell (PEMFC) bioreactor with the cells of interest at the anode. Human 
polymorphonuclear leukocytes (PML) and peripheral blood mononuclear cells (PBMC) were 
isolated from whole human blood, suspended in phosphate buffered saline (PBS) solution and 
introduced to the anode compartment of a proton exchange membrane fuel cell (PEMFC). The 
leukocyte-based PEMFC was allowed to discharge its current across a 100 ohm resistor. 
Measurements of current and open circuit potential were made over time. Small currents 
densities on the order of microamps and open circuit potentials between 100 and 500mV were 
obtained from the leukocyte-based BFCs. In the absence of cells, small currents were also 
observed indicating the presence of small background reactions. The results of this study suggest 
that white blood cells are electrochemically active and contribute to the observed currents from 
the BFCs. The results of this study, however, also emphasize the complexity of electrochemical 
systems, particularly those involving biological organisms.     
 
Keywords: proton exchange membrane, biofuel cell, PML, PBMC, K562 
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5.2 INTRODUCTION 
There has been a lot of work previously on developing microbial fuel cell (MFC) technologies 
[28-30, 34, 35, 37, 38, 40, 43, 47, 68]. In these studies, it was repeatedly demonstrated that many 
types of bacteria can be encouraged to transfer metabolically derived electrons to an electrode. 
Some bacteria have revealed their ability to self-mediate electron transfer without any external 
intervention [29, 30, 36, 37, 47], while other types of bacteria demonstrated a higher electron 
transfer capacity only with the introduction of certain artificial electron mediators or electron 
carriers that shuttle electrons between the metabolic processes of these organisms and the 
electrode surface [28, 34, 35]. With various electrode modifications, including immobilization of 
artificial electron mediators [34, 35] and the placing of electrically conducting polymers [40] 
onto the electrode surface, higher current and power densities continue to be achieved.  
The ability of certain bacteria to transfer electrons directly to metal or carbon-based 
electrodes has been attributed largely to electron transport chain proteins that reside in their cell 
membranes [29, 30]. Bacteria do not have organelles such as mitochondria and, therefore, 
metabolism occurs in the cytosol [69]. Geobacter sulfurreducens is a metal reducing bacteria that 
has been shown to attach to electrode surfaces and are capable of directly mediating electron 
transfer to the electrodes [30]. These bacteria among others belonging to the Geobacteraceae 
family, including D. acetoxidans and G. metallireducens, demonstrated an ability to use 
electrodes as electron acceptors for the oxidation of organic compounds [29]. A membrane-
bound Fe(III) reductase complex (comprising an 89 kDa c-type cytochrome) used by G. 
sulfurreducens to reduce Fe(III) oxides [70, 71] is a possible pathway for the electrons to reach 
the electrode surfaces to which the bacteria are attached [30].    
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Electron transport, pervasive in the plasma membranes of microbes, is generally not 
observed across the extracellular membranes of eukaryotic cells. The presence of an electron 
transport chain in the extracellular membranes of microbes provides a greater likelihood of 
electron tunneling occurring between the membrane-bound species and the electrode surface. An 
electron transport system within the cell, such as in the case of the mitochondrial electron 
transport chain, would be effectively isolated from the electrode surface due the presence of the 
extracellular membrane. In eukaryotic cells, electron transport is a process that is normally 
relegated to the membranes of intracellular mitochondria. Recently, however, a number of 
research articles have been published demonstrating that such electron currents do in fact also 
exist among certain white blood cells. Schrenzel et al. (1998) showed that small currents can be 
measured across the plasma membranes of human eosinophil granulocytes [57]. The experiments 
were performed based on the hypothesis that the membrane associated enzyme NADPH oxidase, 
found in blood phagocytes (e.g. neutrophils and eosinophils), generates superoxide through 
electron transfer from NADPH to extracellular oxygen. The magnitudes of the currents recorded 
across the extracellular membranes were on the order of 10 to 20 pA per cell in these studies.  
The purpose of this study is to investigate whether electron transfer can occur between 
the metabolic processes of human white blood cells and the carbon fiber electrodes of biological 
fuel cells. The hope is to encourage electron transfer between NADPH oxidase and the 
electrodes. From a much broader perspective, the ultimate goal of this project is to develop a 
BFC that may be used within the physiological environment to provide energy to low-power 
implantable medical devices, such as miniature drug delivery devices or biosensors. It is 
expected that with further advances in micro- and nano-technologies that lead to dramatic 
reductions in the size of electronic circuits, energy requirements will decrease for implantable 
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devices.  In addition, the development of novel biomaterials for improved biocompatibility will 
mean that new electrodes can be designed to facilitate specific electrochemical interactions while 
reducing inflammatory responses. With such advancements, it will become possible to design an 
implantable BFC that can transduce the biochemical energy of cells into electrical energy. Our 
research is currently focusing on two main areas: i) in-vitro models to demonstrate that electron 
transfer can be facilitated between human cells and electrodes; and ii) exploring possible means 
of increasing current and power densities from the BFC.  
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5.3 EXPERIMENT I: MATERIALS AND METHODS 
5.3.1 White blood cell isolation 
Human white blood cells, specifically polymorphonuclear leukocytes (PML) and peripheral 
blood mononuclear cells (PBMC), were isolated from 10ml of whole human blood using a 
standard Ficoll-PaqueTM gradient. PMLs include neutrophil, basophil and eosinophil 
granulocytes, while PBMCs include the B and T lymphocytes as well as monocytes. This study 
received prior approval from the Institutional Review Board (IRB) of the University of 
Pittsburgh. The isolation process involved the very careful addition of whole human blood to an 
equivalent volume of the Ficoll solution initially placed in a 50ml tube. Very little disruption of 
the interface between the Ficoll solution and the blood volume should occur, and two distinct 
layers should be perceived without significant mixing at the interface. The two-layer mixture was 
then centrifuged at 2000rpm for 20 minutes, after which four clearly defined layers could be 
perceived: i) erythrocytes or red blood cells at the bottom; ii) clear Ficoll-Paque solution, iii) thin 
layer of PBMCs; iv) blood plasma at the top (Figure 6). The PBMCs were easily removed by 
aspiration using a pipette. The PMLs, however, are more difficult to extract using the Ficoll-
Paque method of isolation. A very thin, almost unperceivable layer of PMLs normally exists just 
above the erythrocyte layer at the bottom of the gradient. The cells from this region were 
carefully aspirated using a pipette and washed at least twice by centrifugation in 50ml 1X 
phosphate-buffered saline (PBS, pH 7.4, Invitrogen, Carlsbad, CA) solution at 1700rpm for 15 
minutes. After washing, the cells were finally resuspended in 10ml PBS at a cell density on the 
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order of 106 cells/ml. The final cell density was determined using a hematocytometer and light 
microscope.  
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Figure 6: Ficoll-Paque gradient for the isolation of human white blood cells from whole human 
blood. 
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5.3.2 Biofuel cell Bioreactor Preparation 
The cell suspension was introduced into the anode compartment of a biofuel cell bioreactor 
(National Center of Biotechnology Education (NCBE), University of Reading, U.K.). The 
cathode solution was made up from 5 mL of 0.1 M potassium ferricyanide and 5 mL PBS (pH 
7.4) to a final volume of 10mL and ferricyanide solution concentration of 0.05M. The anode and 
cathode compartments were separated by a Nafion-117 proton exchange membrane (PEM, 
Sigma-Aldrich, St. Louis, MO). Each compartment had a total working volume of 10ml. Carbon 
fiber sheets (NCBE, University of Reading, U.K.) were used to construct the anode and cathode 
electrodes. The carbon sheets were used due to their high specific surface area. SEM scans of the 
carbon fiber sheets reveal a highly interwoven matrix of cylindrical tubes (Figure 7). The 
dimensions of the electrodes were approximately 2cm x 2cm.  The biofuel cell was connected to 
a 100 Ω resistor, across which measurements of electric potential were made using a standard 
multimeter. A switch was used to make measurements of both the open and close circuit 
potentials across the resistor (Figure 8).  
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Figure 7: SEM scans of carbon fiber electrodes at A) 25X, B) 100X, C) 150X and D) 1500X. 
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Figure 8: Circuit setup for measurement of electrical parameters (open circuit potential and current). 
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5.3.3 Cell activation and chemical manipulation 
In order to achieve cell (and NADPH oxidase) activation, 10ul each of phorbol-12-myristate-13-
acetate (PMA, 5µg/ml) and calcium ionomycin (500µg/ml) were added to the 10mL cell 
suspension to reach final concentrations of 5ng/ml and 500ng/ml, respectively. Based on the 
theory that NADPH oxidase can mediate electron transfer to an electrode, two hypotheses for the 
mechanism involved in the electron transfer process were developed: 1) direct electron transfer 
occurs (through electron tunneling) between the electron donor site of the NADPH oxidase 
complex (cytochrome b558) and the electrode; 2) indirect electron transfer occurs as a result of 
the oxidation of the reactive oxygen species (ROS) released by the cells during the simulated 
respiratory burst at the electrode surface. The effect of a non-ionic detergent, Igepal (Sigma 
Aldrich, St. Louis, MO), was investigated. If any observed currents are mediated by NADPH 
oxidase and electron transfer occurs through either of the proposed mechanisms, then the 
introduction of the detergent would effectively extinguish the currents by disrupting the lipid 
membrane and consequently the enzyme complex.  
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5.4 EXPERIMENT I: RESULTS AND DISCUSSION 
BFC Currents and Open Circuit Potentials 
Small electrical currents on the order of 0.1 to 0.2mA were observed for the two leukocyte-based 
biofuel cells containing PBMCs in one and PMLs in the other (Figure 9). The currents from the 
PML-based BFC increased from an initial average current of 0.17 mA to 0.19 mA by the end of 
the recording period, while for the PBMCs the average current increased from 0.12 to 0.16 mA. 
As described previously, current values were determined by measuring the electric potential 
across a 100 Ω (+/- 5%) resistor using a BK Tookit 2707A multimeter (accuracy +/- 0.05% + 1 
digit).  The current measured was associated with a systematic error of +/- 6%. Currents 
measured for the individual PML and PBMC samples are shown in Figure 10 and Figure 11, 
respectively. A clear difference in the behavior of the current output over time can be discerned 
between the PMLs (Figure 10) and the PBMCs (Figure 11). In one experiment, the current from 
the PBMC-based BFC was much lower than expected, starting at 0.031 mA, and then increasing 
dramatically to a final current of 0.18 mA (PBMC Sample I). In another instance, there was an 
unexpected decrease in the current output of the PBMC-based BFC and then a subsequent 
increase in the current (PBMC Sample II). PBMC sample III had slightly larger currents than the 
first two samples; however, there was also some variation in the current output, with a slight dip 
in the current measurement at about 25 minutes. Compared to the PMLs, the current output of 
the PBMCs proved to be very unstable, with dramatic changes observed during small 
perturbations of the fuel cell apparatus. Such dramatic changes during perturbation of the BFC 
apparatus were not observed in the case of the PMLs. One explanation for the instability in the 
current output could be postulated to be a faulty connection between the BFC and the electronic 
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circuit used for the measurement of current and potential. The instability in the current output 
could be blamed on faulty connections between the BFC and the electronic circuit used for the 
measurement of current and potential.  
The open circuit potentials recorded from the BFCs also proved to be rather unstable for 
both the PMLs and PBMCs, normally starting at an initial value of about 500mV and decreasing 
to final potentials of about 300mV by the end of the recording period (results not shown). The 
fact that an increase in current was observed with time for both the PMLs and PBMCs in spite of 
a decreasing open circuit potential was a confusing result. Due to polarization effects and 
increases in internal resistance normally associated with electrochemical systems, a decreasing 
open circuit potential would normally be associated with a decreasing current. In these studies, 
however, this was not the case.  
   
Background reactions and currents 
A weak correlation between current and cell density was shown to exist for both the PML and 
PBMC-based BFCs (Figure 12 and Figure 13). For the PBMCs (Figure 13), the average current 
for Sample 1 was much lower than would be expected for the corresponding cell density when 
compared to Samples 2 and 3. There are a number of reasons that could explain this observation. 
The lack of good cell-electrode electrical interactions, cell inactivity or low cell activity, and 
unusually high internal resistance due to extensive electrode fouling and PEM obstruction could 
all be possible explanations for the lower than expected current. The lack of a stronger 
relationship between cell density and the average current may also suggest that other factors 
apart from the cells themselves are contributing in whole or in part to the observed currents.  
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The issue of possible background currents occurring within the BFC system as a result of 
non-cellular interactions was also supported by the observance of significant currents in the 
absence of cells at the BFC anode (Figure 14, Figure 15, Figure 16). These currents were 
normally smaller in magnitude than the currents observed in the presence of the cells, 
particularly during the initial measurement period (Figure 16). The currents increased gradually 
with time. There was also an unusual instance where the magnitude of the current measured for 
one of the controls was on the same order of magnitude as that obtained from the experiments 
with the white blood cells (Figure 15 and Figure 16). The profile of the current in this particular 
instance; however, was slightly different from that obtained with the cells. The current in this 
instance appeared to increase gradually from its initial value and began to decrease after 
achieving a peak current value of 0.14 mA. This dome-shaped profile was not characteristic of 
any of the experimental cases involving either the PBMCs or PMLs.  
The addition of PMA and ionomycin was often associated with an increase in the current 
output of the BFC, indicating that both activating agents do have some electroactive capacity, a 
fact that further confounds the experimental results and contributes to the complexity of the bio-
electrochemical system. The electrochemical activity of all chemical agents used must be taken 
into consideration in further experimental designs.  
 
Electricity generating ability of white blood cells 
Currents from the BFC containing cells were generally higher than currents from those without 
cells at the anode (Figure 16), strongly suggesting that the white blood cells are contributing to 
the observed currents. However, the exact mechanism by which the cells transfer electrons to the 
electrode as well as the extent to which they contribute to the observed currents is not 
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immediately apparent. There is the possibility that electron transfer might occur via the reduction 
of superoxide radicals released by NADPH oxidase at the anode. NADPH oxidase might also be 
capable of directly mediating electron transfer to the electrodes without the intervention of 
chemical mediators. Such a direct electron transfer to plain carbon fiber electrodes, however, is 
not likely due to the environmental conditions (an aqueous, oxygenated anode compartment) 
which are unfavorable for electron tunneling between the redox active centers and the electrode 
surface. When the non-ionic detergent, IgepalTM, was added to the cell suspension comprising 
the PMLs, a decrease in current was observed. In spite of the decrease, however, the current 
generated by the BFC was not completely extinguished (see Figure 16) and a subsequent 
increase in the current, was observed. This increase, however, should not be surprising. 
Disruption of the cell membrane would inevitably lead to expulsion of the intracellular contents 
of the white blood cells. A large number of the biochemical species that would be expelled are 
electrochemically active, such as the numerous coenzymes involved in the various cellular 
metabolic pathways. These species could all interact electrochemically with the electrode 
surface.  
 
Impurity of PMLs 
Polymorphonuclear leukocytes include neutrophils, basophils and eosinophils. In this study, an 
attempt was made to isolate these cells from whole blood on a Ficoll gradient. The cells were 
aspirated using a pipette from the region just above the red blood cell layer. Although a large 
proportion of these cells may actually be PMLs, many of the cells isolated may also belong to the 
PBMC type, including the B and T lymphocytes and monocytes. The purity of the PML samples 
is, therefore, questionable with respect to these experiments and consequently, it is impossible to 
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attribute the currents observed entirely to the PMLs. The currents observed from the PML-based 
BFCs may be the result of contributions from the PMLs as well as the PBMCs.  
 
Possible sources of background currents 
The observation of currents in the absence of the white blood cells as well as the very weak 
correlation between cell density and current are both indicators that there are background 
reactions unrelated to the cells that are present within the electrochemical system. The decrease 
in the current produced from the PML-based BFC upon introduction of the Igepal detergent also 
cannot be confidently taken as the consequence of an electrical pathway disruption between cell 
membrane proteins (of NADPH oxidase) and the carbon fiber electrode surface (Figure 17). A 
much simpler explanation may be presented, such as the formation of an Igepal overlay on the 
electrode surface that impedes the kinetics of the unknown reaction.  
Closer inspection of the bioreactor system and the electrode-circuit connections revealed 
the formation of a bluish-green substance at the interface between the carbon fiber electrodes and 
the electrical circuit. It was also noted that the highly absorbent carbon fiber anode and cathode 
electrodes were thoroughly soaked with their respective compartment solutions. It was 
hypothesized that significant background currents may have occurred as a result of chemical 
reactions at the carbon fiber electrode-circuit interface. The alligator clips used to attach the 
carbon fiber electrodes to the resistor had undergone some corrosion, which likely resulted in an 
electrochemical interaction when contact with the compartment solutions were made. The 
experiment was, therefore, repeated with small strips of stainless steel inserted between the 
alligator clips and carbon fiber electrode connections. Stainless steel was selected due to the fact 
that it is both easily available and relatively inert. In Figure 14 and Figure 15, one would 
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immediately notice that the magnitude and profile of the current obtained for the control 
experiment when stainless steel was used to protect the interface differed greatly from the 
previous control experiments with PBS at the anode.   
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Figure 9: Average currents (n=3) for 1) PML-based BFC and 2) PBMC-based BFC. 
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Figure 10: Current output from a BFC containing human PMLs. A gradual increase in current was 
observed over the one hour period of measurement for all samples (current measurement accuracy +/- 6%). 
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Figure 11: Current output from a BFC containing human PBMCs. The current from these BFCs 
were generally unstable and for two of the samples showed large variations in their current as a function of 
time (current measurement accuracy +/- 6%). 
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Figure 12: Relationship between cell density and average current. Very little correlation is observed 
between the two parameters, indicating that other factors are involved in the generation of the observed 
currents that are separate from the cells. 
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Figure 13: A relationship between the average current and PBMC cell density was investigated. 
However, no correlation was observed. These results strongly suggest that there may be additional factors 
(reactions)   responsible for the observed currents. 
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Figure 14: Controls: Plain PBS was introduced into the anode compartment of the BFC, while a 
ferricyanide solution made up in PBS was introduced into the cathode solution. Despite the absence of cells in 
the solution, currents of significant magnitude were observed. Upon using stainless steel to ensure that the 
anode and cathode solutions did not come into contact with the alligator clips, the current from the BFC 
decreased dramatically and resulted in a current output that decreased monotonically with time. 
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Figure 15: Overall results of experiments and controls. Strips of stainless steel (ss) were used to 
bridge the connection between the carbon fiber electrodes and the alligator clips connected to the 100 Ohm 
resistor. A “direct connection” signifies that the carbon fiber electrodes were directly in contact with the 
alligator clips. 
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Figure 16: Current output from three PML-based BFCs and four control experiments. Introduction 
of Igepal to the anode compartment containing the PMLs resulted in a slight decrease in current. The current 
was not completely extinguished and subsequently began to increase. In the case of the control experiments 
(no cells), currents of variable magnitude were observed. Noticeable was the fact that addition of PMA and 
ionomycin to the anode compartments of the bioreactors without cells resulted in significant increases in 
current, with the exception of one case. 
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5.5 EXPERIMENT II: MATERIALS AND METHODS 
5.5.1 White blood cell isolation 
Human white blood cells (WBC) were isolated from approximately 10mL of whole human 
blood. The total WBC population was isolated using a red blood cell (RBC) lysis technique.  
This required preparation of a 3:1 ratio of RBC lysis solution from a Puregene® kit (Gentra, 
Minneapolis, MN) solution to whole blood, which was allowed to sit for approximately 10 
minutes and then centrifuged at 2000 rpm for 10 minutes. The supernatant containing the lysed 
red blood cells was removed and the remaining WBC pellets subsequently washed multiple 
times (at least three times) in 1X PBS. After washing, the cells were finally resuspended in 15ml 
PBS. For specific isolation of PBMCs, a Ficoll-PaqueTM density gradient was used as described 
previously. The cells were washed twice in PBS (pH 7.4) by centrifugation at 1600 rpm for 15 
minutes and were finally resuspended in 15mL PBS. Cells from a K562 (monocyte progenitor 
cells) cell line were also cultured over a period of one week in RPMI with 10% fetal bovine 
serum (Invitrogen, Carlsbad, CA). The cells were extracted from the culture media by 
centrifugation (1700 rpm for 15 mins), washed twice and finally resuspension in 1X PBS. A light 
microscope and hematocytometer were used to determine the final cell densities in PBS.  
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5.5.2 Measurement of open circuit potential and current 
Multimeters were used to measure the open-circuit potential, Voc, as well as the potential across 
a 100Ω (+/- 5%) resistor, Vr, during current flow through the BFC. Current, I (µA), and current 
density, J (µAcm-2), were found using Ohm’s law. The surface area of the electrodes was taken 
as the geometric surface area and not the actual surface area. Woven carbon fiber electrodes (8.0 
cm2 geometric surface area) were used for both the anode and cathode electrodes. The cell 
suspensions were confined to the anode compartment, while the cathode compartment contained 
a 50mM potassium ferricyanide (K3[Fe(CN)6]) solution made up in 1X PBS (pH 7.4). The anode 
and cathode electrodes were separated by a proton exchange membrane (PEM). WBC activation 
was achieved with 5ng/ml phorbol-12-myristate-13-acetate (PMA) and 500ng/ml calcium 
ionomycin (final concentrations in solution). The components used to construct the BFC, 
including the walls, chamber and carbon fiber electrodes, were purchased from the National 
Center of Biotechnology Education (NCBE), University of Reading (United Kingdom). The 
Nafion-117 proton exchange membrane was purchased from Sigma-Aldrich Co (St. Louis, MO). 
Strips of stainless steel were used as an interfacial connector between the carbon fiber electrodes 
and the alligator clips with leads to the resistor, in order to prevent the anode and cathode 
solutions from reacting with elements within the clips.  
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5.6 EXPERIMENT II: RESULTS AND DISCUSSION 
BFC Currents and Open Circuit Potentials 
In a preliminary experiment, where the current output for a BFC containing WBCs (isolated by 
RBC lysis) was measured (Figure 18), current densities (J) between 1.0 and 1.6 µAcm-2 (between 
8 and 13 µA) were measured for PMA activated cells and current densities between 1.1 and 2.6 
µAcm-2 (9 and 21 µA) were measured for non-activated cells (current density error +/- 5%). 
Open circuit potentials (Voc) ranged between 202mV and 285mV for the activated cells, while 
the range was between 180mV and 350mV for the non-activated cells (electric potential error +/- 
0.5%). In a second experiment, where the current output of PBMCs (isolated on Ficoll-Paque 
gradient) in a BFC were measured (Figure 19), current densities between 0.1 and 0.5 µAcm-2 (1 
and 4µA) were obtained for the PMA activated cells. For non-activated cells, the current 
densities recorded ranged between 0.4 and 0.6 µAcm-2 (3 and 5 µA), which were slightly higher 
than the previous case (activated cells). The error associated with the current measurements was 
+/- 5%. Open circuit potentials for the PBMCs ranged between 62 and 159mV for the activated 
cells and between 180 and 350mV for the non-activated cells (error +/- 0.5 %). Voc and J values 
for the WBCs were higher than control values, i.e. compared to anode solutions of (1) plain PBS 
and (2) PBS with activating agents PMA and ionomycin (Figure 21). In the absence of white 
blood cells, small currents could still be detected when the anode compartment contained a 
solution of PBS, PMA and ionomycin (Figure 21).  
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PMA and ionomycin electrochemical activity 
The fact that currents were observed with PMA and ionomycin dissolved in PBS is an indication 
of their electrochemical activity. Cyclic voltammetry of a PBS solution with dissolved PMA and 
ionomycin, at similar concentrations to that used in this experiment, resulted in no observable 
oxidation or reduction peaks (results discussed in Section 6.0). The electrochemical activity of 
PBS, PMA and ionomycin leading to currents in the bioreactor system should be associated with 
oxidation peaks in the cyclic voltammograms. The absence of any observable peaks may be a 
consequence of the very low concentrations of the reactants, which fall outside the detection 
limits of cyclic voltammetry. A PEMFC containing plain PBS only at the anode did not produce 
any observable currents or open circuit potentials (Figure 21).  
 
Relationship between Voc and J 
WBC activation with PMA was associated with high correlation coefficient values (R2 values) 
for Voc plotted against J in contrast to non-activated cells (Table 4). The same was true for the 
PBMCs. A high correlation coefficient (close to 1.00) may be an indication of a dominant 
reaction that is fully responsible for driving the observed currents. The relationship between Voc 
and J for the activated WBCs was strongly linear and was not observed for any other situation.  
 
Decreasing open circuit potentials 
In Figure 18 and Figure 19, the open circuit potential noticeably decreases over time. The same 
was also true for the closed circuit current. The decreasing potential may be a consequence of the 
method employed in acquiring the data. Measurements of open circuit potential and the closed 
circuit potential across the resistor (used to calculate current from Ohm’s law) were made every 
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10 minutes. After the circuit is closed to measure current, upon reverting to an open circuit, the 
reactants at the anode and cathode would require some period of time to achieve equilibrium. 
Achieving this equilibrium state may take more than 10 minutes. Therefore, the open circuit 
potential measured at each time interval was actually lower than the true value. The current 
values may also be lower than their true values due to the rapid polarization that would occur 
upon closing the circuit. The effects of polarization may have been reduced by using a much 
higher external resistor.         
 
Evidence supporting electrochemical activity of WBCs 
In Figure 20, J values measured for PBMCs only (BFC I) and WBCs (BFC II) are plotted against 
time. As mentioned previously, the current output for the WBCs was higher than that of the 
PBMCs. By replacing the original WBC cell suspension with PBS containing PMA and 
ionomycin, the current output of BFC II decreased significantly. No significant change in current 
was observed when the PBMCs were replaced in BFC I. One possible explanation that could be 
put forward for the relatively larger currents and potentials observed with WBCs at the anode 
compared to other preparations may be that residual substances from the isolation process could 
have contaminated the anode solution and the electrodes, leading to some electrochemical 
activity. In an attempt to disprove this explanation, samples of the PBS supernatant from 
washing the cells were saved and later introduced at the anode of the PEMFC. By acquiring the 
supernatant from the first wash, it would be highly likely that any residual substances would 
remain dissolved in the PBS at a much higher concentration than would be found in the final cell 
suspension. This was done for both the WBCs and PBMCs. The results of this experiment can be 
found in Figure 22 and Figure 23. In both cases (WBCs and PBMCs) there is a clear increase in 
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potential and current when the supernatant is replaced by the cell suspension. In order to ensure 
that the increase is not due to changing pH, measurements of the acidity of the cell suspensions 
were recorded after PMA activation for at least 30 minutes. The pH of the suspension remained 
at around 7.5, which is approximately the same pH as the original PBS solution. Therefore, there 
is not a significant enough change in the concentration of protons in solution to warrant a 
dramatic change in the pH of the buffer and thus an increase in the rate of reaction (resulting in 
increased current) or a change in the reduction potential, E0’.  
 
Investigation of the electrochemical activity of K562 cells 
The current output and open circuit potential of a PEMFC containing K562 cells were also 
investigated (Figure 24). The currents in the presence of a K562 cell suspension proved to be 
rather small (average current density of 0.4 µAcm-2) despite the relatively large open circuit 
potentials recorded. In addition, the correlation coefficient (expressed as its square value, R2) 
between Voc and J was smaller than that determined for the WBCs.  
 
Identifying cell types responsible for the currents 
In Figure 25, the average currents and average open circuit potentials were plotted with respect 
to the specific cell populations at the anode, as well as with respect to the cell density in the PBS 
suspension. The highest average currents were associated with the white blood cell suspension 
(regardless of whether they were stimulated or not). Within this white blood cell population, it is 
expected that the following specific cell types would be found: neutrophils, basophils, 
eosinophils, monocytes, PBMCs. Since the PBMCs appear to be associated with very small 
currents, it is not likely that these currents contribute significantly to those observed for the total 
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WBC population. The results imply that within the general WBC population, certain cells or 
perhaps even the molecules released by certain cells are electrochemically active at the electrode 
surface. Although the exact source of the currents observed is not clear, they may be attributed to 
the oxidation of electrochemically active species that are either released by the cells into the 
extracellular environment (such as serotonin, cytokines) or by redox active species that are 
present in the cell membrane (such as flavohemoproteins of the NADPH oxidase complex or 
coenzyme A). It has proven difficult, however, to ascertain the exact identity of the species being 
oxidized at the anode. In order to be able to produce a current from the BFC, protons must also 
be released by the cells into the extracellular space. The increase in proton concentration in the 
anode compartment is important to create a diffusion gradient, whereby the protons can traverse 
the PEM to react with molecular oxygen to form water at the cathode. Placing either PBS 
solution or deionized water in both the anode and cathode compartments did not produce any 
detectable currents and were associated with open circuit potentials that were less than 20mV.  
Average open circuit potentials and average current densities (n=3) were compared for 
the PEM fuel cell containing i) activated WBCs and ii) PBS with PMA and ionomycin at the 
anode (Figure 26 and Figure 27). The magnitude of the values for both average Voc (Figure 26) 
and average J (Figure 27) were higher for the WBC suspension than for a solution of PBS, PMA 
and ionomycin at the anode. For both the WBC suspension and PBS solution, large variations in 
Voc were observed across the three samples, leading to rather large standard deviations. These 
large standard deviations were a stark contrast to those observed for the average current density, 
particularly at later time points. Toward the end of the 60 minute period of measurement, there 
was a noticeable decrease in the standard deviation associated with the average current densities. 
The fact that Voc and J are generally larger for the WBC suspension than for the PBS solution 
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suggests that the cells are largely responsible for the observed currents. There is an evident 
contribution from reactions associated with PMA and ionomycin at the anode. Identification of 
the specific chemical agent, PMA or ionomycin that is actually electrochemically active was not 
determined. The fact that higher overall current densities are produced by the total WBC 
population compared to the isolated PBMCs strongly supports our theory that 
polymorphonuclear leukocytes (PML) – to which neutrophils, eosinophils and basophils belong 
– are the primary contributors to the observed currents. The PBMCs have much less of a 
respiratory burst response and have a very low density of NADPH oxidase in the cell membranes 
compared to PMLs. This is true for most, if not all, PBMCs (including monocytes). A low 
respiratory burst would correspond to very little proton release by the cells, which directly 
impacts the observable currents since proton translocation across the PEM now becomes a 
limiting factor.  
 
Polarization effects  
Regardless of how significant the open circuit potential of the PEM fuel cell may be, there will 
be very limited current and consequently low power generation as a result of the lack of a 
sufficient proton gradient between the anode and cathode compartments. A low proton gradient 
would therefore translate into a very high internal resistance, Rm (resistance of the PEM), and as 
a result a significant ohmic overpotential (polarization). Potential losses are associated with 
charge transfer at the electrode surface (activation polarization), diffusion effects (concentration 
polarization), and the resistance of the PEM (ohmic polarization). The large voltage losses 
associated with the BFC is clearly observed once the circuit is closed. There is an almost 
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immediate and rapid drop in potential from the initial open circuit potential values - on the order 
of hundreds of millivolts - to only tens of millivolts.  
 
Implications of study with respect to the development of an in vivo BFC power supply 
In this study, we proposed the development of a novel biological fuel cell that can utilize the 
body’s own resources to generate electricity, through specific electrochemical interactions 
between cells and electrodes in close proximity. The motivation of this study was to develop a 
BFC that can be used to power implantable medical devices, including micro- and nano- 
biosensors for either therapeutic or physiological monitoring purposes. The study sought to 
demonstrate that electron transfer between human white blood cells and an interfacing electrode 
can occur through any or all of three possible mechanisms: 1) direct electron transfer through 
membrane bound redox species (such as the flavocytochrome of NADPH oxidase); 2) indirect 
electron transfer through exocytosed non-metabolic biochemical species; and 3) indirect electron 
transfer through exocytosed metabolically relevant biochemical species.  
A significant hurdle at this point is the necessity of the proton exchange membrane 
(PEM) to separate the anode and cathode compartments. A PEM would make it difficult to 
incorporate a biofuel cell into the human body. However, a solution might already exist. In 
articles by Mano et al. [19, 20, 49], an enzymatic biofuel cell was described that facilitated the 
reduction of molecular oxygen to water at the cathode through an enzyme that was immobilized 
at the electrode surface.  Glucose oxidase was immobilized at the anode to facilitate the 
oxidation of glucose to gluconolactone. The enzymatic biofuel cell was able to generate 
potentials as high as 800mV, which is several times larger than what we were able to produce in 
our own studies (200mV). Our biological fuel cell, however, may have the advantage of 
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simplification compared to the enzymatic biofuel cell previously described, in that it would not 
be necessary to modify the anode electrode. An 800mV potential may also not be necessary for 
certain applications.   
This research started with the goal of using NADPH oxidase as a mediator of electrons 
between the biological cells and the anode electrode of a biofuel cell. However, over the course 
of this research project, it was found that such a direct electron transfer is very difficult to 
accomplish. Previous studies performed by other researchers on microbial fuel cells suggested 
that under normal conditions, it is very difficult to achieve direct electron transfer between the 
cell membrane components of the microbes and an interfacing electrode. An important reason for 
this is the fact that the redox active groups are generally embedded within integral membrane 
proteins, resulting in a significant energy barrier that increases with increasing distance between 
electron donor and receptor pairs. Electron tunneling between the membrane components and the 
electrode surface is further discouraged because of the thermodynamically unfavorable 
conditions surrounding the movement of free electrons through an aqueous solution. In order to 
overcome this challenge, many microbial fuel cell researchers employed electron mediators that 
were capable of shuttling electrons between the membrane-bound redox active components of 
the microbes and the electrode. The use of these electron mediators significantly increased the 
efficiency in electron transfer and thus the current output of the microbial fuel cells.  
 
Difficulties associated with electron transfer between NADPH oxidase and an electrode 
In our own study, the fact that we are dealing with eukaryotic cells makes the situation a bit 
complicated for in-vitro analysis in a biofuel cell setup. White blood cells, like all other cells in 
the human body, require oxygen in order to metabolize glucose to produce ATP. A problem with 
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many variations of biofuel cells, particularly those dependent on whole cells, is the fact that 
oxygen is under most circumstances the preferential electron acceptor for the metabolic 
processes that occur in both prokaryotes and eukaryotes. It is the final electron acceptor at the 
plasma membrane for most prokaryotes and within the mitochondrial membrane of eukaryotes. 
Oxygen is also the final electron acceptor of the activated NADPH oxidase complex. In the case 
of microbial organisms, eliminating oxygen from the anode compartment is not a major issue 
and is not detrimental to the microbes, since electrons can be diverted to the anode electrode, 
through an electronic circuit and finally oxygen at the cathode. There are usually no other 
metabolic processes within the microbes that would be dependent on the presence of oxygen. 
When dealing with human white blood cells, however, it is not possible to eliminate oxygen 
completely from the anode compartment due to the fact that oxidative metabolism in the 
mitochondria requires oxygen in order for the cell to survive. The presence of oxygen around the 
cell would also mean that electrons available in the NADPH oxidase complex would be 
preferentially transferred to any oxygen molecule in close proximity. Very few or no electrons 
would be transferred to an unmodified carbon felt electrode. Dissolved oxygen in the 
surrounding extracellular fluid would ultimately succeed in grasping up the electrons before they 
could ever be transferred to the electrode surface. It is possible, however, as demonstrated in the 
BFC results presented previously, that there is some mechanism of electron transfer that occurs 
upon the stimulation of the white blood cells. One possibility is that free radicals, such as 
reactive oxygen species (superoxide and peroxide), released by the NADPH oxidase complex, 
could undergo irreversible oxidation at the anode electrode. The simultaneous ejection of protons 
from the cell to compensate for the electron transfer would facilitate the generation of electrical 
currents as the build up in the proton concentration would lead to a diffusion gradient that drives 
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the movement of protons from the anode to the cathode chamber, where they finally combine 
with oxygen to form water. The observation that currents are produced for unstimulated cells 
suggests that there may be either other mechanisms of electron transfer or that some 
contamination is occurring. One other possibility for an electron transfer mechanism is oxidation 
of coenzyme A (CoA) present in the cell membrane [72, 73].  
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Respiratory burst 
 
 
Figure 17: NADPH oxidase and respiratory burst in phagocytic white blood cells. 
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Figure 18: Stimulated (left panels) and non-stimulated (right panels) white blood cells (isolated using 
RBC lysis technique). 
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Figure 19: Stimulated (left panels) and non-stimulated PBMCs (right panels). 
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Table 4: Correlation coefficient values (expressed as R2) for Voc vs.  J 
 
Anode solution R2
Activated white blood cells 0.99 
Non-activated white blood cells 0.30 
Activated PBMCs 0.57 
Non-activated PBMCs 0.21 
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Figure 20: Comparison of currents acquired from experiments (PMA activated cells) and controls 
(PBS with PMA). 
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Figure 21: Plain PBS (top) and PBS with PMA and ionomycin (bottom). 
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Figure 22: Comparison between BFCs containing WBC supernatant, non-activated WBCs and activated 
WBCs. 
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Figure 23: Comparison between BFCs containing PBMC supernatant, non-activated PBMCs and activated 
PBMCs. 
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Figure 24: Activated (left panels) and non-activated (right panels) K562 cell line. 
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Figure 25: Relationship between cell density and electrical parameters (average current and average open 
circuit potential during 60 minute period of measurement). 
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Figure 26: Comparison between average open circuit potentials (n = 3) for PEM Fuel cell with activated 
cells (blue) and with PBS with PMA and ionomycin (red). 
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Figure 27: Comparison between average current densities (n = 3) for PEM fuel cell with activated cells 
(blue) and with with PBS with PMA and ionomycin (red). 
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5.7 CONCLUSIONS 
The results of this study suggests that human white blood cells isolated from whole 
human blood are capable of generating small electrical currents and potentials when introduced 
into the anode compartment of a PEM fuel cell bioreactor. Average open circuit potentials with 
the white blood cells ranged between 100 and 200mV (Figure 26), while average current 
densities (calculated with respect to the geometric surface area of the carbon fiber electrodes) 
ranged between 0.8 and 1.8µAcm-2 (Figure 27). The magnitude of these currents and potentials 
are insufficient for current applications in the field of medical devices (see summary of electrical 
stimulation parameters for implantable devices in Table 1). However, with ever decreasing 
power requirements for devices due to advances in the field of micro- and nano-technologies, 
such a power source may feasibly be implemented. The isolated PBMCs as well as cells cultured 
using the K562 leukemia cell line demonstrated very little electrochemical activity when 
introduced into the PEM fuel cell bioreactor. The fact that there was a lack of strong evidence 
suggesting that PBMCs are electrochemically active imply that some other white blood cell type, 
such as the human granulocytes (neutrophils, basophils, eosinophils) might play a greater role in 
the generation of the observed currents. A major concern in investigating such an 
electrochemical system is the fact that background currents may at times be larger than expected 
(such as was observed in Experiment I), and could essentially mask smaller currents elicited by 
the cells themselves and/or confound the results of the experiments. The enzyme complex 
NADPH oxidase has been reported to generate electronic currents on the order of 10 to 20pA by 
various research groups. For cell densities on the order of 106 cells/ml in 10ml volumes of the 
cell suspensions (107 cells) maximum currents of only 200µA would be expected. With 
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limitations within the biofuel cell system related to low electron transfer efficiencies at the cell-
electrode interface, high internal resistance associated with the PEM and electrodes, low cathode 
reaction rates, the current output would end up being several orders of magnitude smaller than 
this ideal case value. An attempt was made in this study to determine whether electron transfer 
can occur between human white blood cells and carbon fiber electrodes within the context of a 
biofuel cell system. Employing such a system, however, is inadequate in itself to prove 
conclusively that such electron transfer can occur and to verify the mechanism of electron 
transfer. As a result, electrochemical techniques such as cyclic voltammetry will become 
necessary to further explore the electron transfer capability of human white blood cells.  
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6.0 CYCLIC VOLTAMMETRY AND HPLC OF LEUKOCYTES 
6.1 ABSTRACT 
In previous studies by our group, the ability of human white blood cells (WBC) to generate 
electrical currents when introduced at the anode of a proton exchange membrane (PEM) fuel cell 
has been investigated. The primary goal of those studies was to promote electron transfer (ET) 
between intracellular metabolic processes and extracellular carbon felt electrodes. In this study, 
cyclic voltammetry (CV) is used to further investigate the electrochemical activity of activated 
human WBCs to identify possible mechanisms of ET, as well as to identify species that are 
released by these cells, which may undergo oxidation-reduction reactions at the electrode 
surface. Cyclic voltammograms were obtained for human WBCs, specifically PBMCs 
(lymphocyte-monocyte mixture isolated on a Ficoll gradient), a B lymphoblastoid cell line 
(BLCL), and two leukemia cell lines, namely K562 and Jurkat. Cyclic voltammograms of the 
PBMCs revealed oxidation peaks at an average potential of 368mV vs. SCE for PMA and 
ionomycin activated cells isolated from five human subjects. Corresponding reduction peaks 
were not observed in the cyclic voltammograms of the activated cells. Similar oxidation peaks to 
those observed for PMA activated PBMCs did not appear in the cyclic voltammograms of the 
BLCL, K562 or Jurkat cell lines regardless of whether they were activated or not. Previous 
studies by other research groups have described oxidation peaks associated with both human and 
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rat leukocytes that have been attributed to the release of serotonin (5-HT) from intracellular 
stores. The identity of serotonin was verified by high performance liquid chromatography 
(HPLC) with electrochemical detection.  
 
Keywords: Serotonin, Cyclic voltammetry, HPLC, PBMC, PMN, BLCL, Jurkat, K562 
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6.2 INTRODUCTION 
Electrochemical analyses of biological systems can be rather complicated due to the vast number 
of electrochemically active species that are either released by biological cells into the 
extracellular environment or that are present in the plasma membranes of these cells. Previous 
research by our group has sought to demonstrate the feasibility of generating small electrical 
currents when white blood cells (WBC) are introduced to the anode of a proton exchange 
membrane (PEM) fuel cell [13, 14]. The goal of these previous studies was to explore whether 
the plasma membrane bound protein complex, NADPH oxidase, is capable of self-mediating 
electron transfer between intracellular NADPH and an interfacing electrode. Establishing 
electrical communication channels between the redox centers of membrane bound proteins and 
an electrode is, however, one of the fundamental difficulties facing the development of 
bioelectronic systems. Undertaking an electrochemical analysis of membrane protein complexes 
can be confounded by the activity of myriad other species that may be present in the plasma 
membranes of the cells - such as coenzymes - or by various species that are released by cells in 
their activated states, such as cytokines, histamine and serotonin (normally released by 
leukocytes during an allergic or inflammatory response). Cyclic voltammetry (CV) studies 
performed by other research groups have identified oxidation peaks associated with serotonin (5-
HT) release by white blood cells [72-74], specifically human neutrophils and rat basophilic cells. 
The peaks were normally observed with the application of various allergens to the WBC 
population at a potential of 330mV vs. SCE [73]. In this work, results from recent studies 
investigating the electrochemical activity of human WBCs are presented and discussed. Of 
particular interest was the lymphcoyte and monoycte cell population – or peripheral blood 
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mononuclear cells (PBMCs) – and the release of biochemical species, such as 5-HT, upon 
activation with PMA and ionomycin. Phorbol esters, such as PMA, are used to activate cells via 
a protein kinase C (PKC) pathway [75]. The electrochemical activity and release of 5-HT from 
BLCL (B lymphocyte cells), K562 (a monocyte progenitor cell line) and Jurkat (a T lymphocyte 
progenitor cell line) were also investigated. HPLC was used to verify the presence of 5-HT.  
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6.3 MATERIALS AND METHOD 
6.3.1 Cyclic Voltammetry 
A three-electrode electrochemical setup was employed for the cyclic voltammetry study. The 
system consisted of a working electrode, which is the site of charge transfer (where the reaction 
under investigation occurs), and a counter electrode, which serves to complete the circuit. The 
third electrode, the reference, functions just as its name implies. It is used as a reference for 
measurements of potential recorded at the working electrode.  The reference electrode is 
designed to have a very high input impedance and as a result, remains unsusceptible to changes 
in its potential due to the affects of polarization, as only very small currents can flow through. 
The fact that the reference potential remains relatively constant means that accurate 
measurements of potential at the working electrode can be made. The majority of the current that 
flows within the three-electrode electrochemical cells flows between the working and counter 
electrodes and can be simultaneously measured along with potential. Cyclic voltammetry 
provides plots reflecting the relationship between current (i) and potential (E). The resultant i-E 
plot for a redox species in solution has a characteristic “duck” shape, consisting of an oxidation 
and reduction peak. The potential that corresponds to the middle of the two peaks is usually 
taken as the midpoint potential, Em. Using the Gamry interfacial software, parameters such as the 
voltage scan range, scan rate, maximum current and electrode surface area can be specified.  
Cyclic voltammetry was performed using the Gamry Potentiostat, FAS2/Femtostat under 
control of the Gamry Framework Software from Gamry Instruments. The Gamry Software is 
installed on a Dell Dimension 2400 Desktop Computer. A three-electrode setup was used, where 
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carbon felt and platinum served as the working and counter electrodes, respectively, while a 
saturated calomel electrode (SCE) served as the reference. Phorbol-12-myristate-13-acetate (final 
concentration of 5ng/ml) and calcium ionomycin (final concentration of 500ng/ml) were used to 
activate the white blood cells. White blood cell activation occurs as a result of non-specific 
Protein Kinase C (PKC) pathways. Four WBC samples were studied, namely human peripheral 
blood mononuclear cells (PMBC), cells derived from K562, a BLCL and Jurkat cell line.  
This study was approved by the Institutional Review Board for Human Subject Research 
of the University of Pittsburgh. Human white blood cells were isolated from approximately 
12mL of whole human blood using a Ficoll-PaqueTM density gradient. Briefly, whole blood was 
gently added, using a pipette, to an equivalent volume of the Ficoll-PaqueTM solution to obtain 
two clearly defined layers. After centrifugation at 2000 rpm for 20 minutes, four clearly defined 
layers can be discerned for the gradient – red blood cells at the bottom, followed by a larger 
volume of the Ficoll solution, then a thin layer of white blood cells (consisting primarily of 
PBMCs) and finally a larger volume of blood plasma. The thin PBMC layer comprising the B 
and T lymphocytes was carefully recovered using a pipette. The cells were washed twice in 
phosphate-buffered saline (PBS) solution (pH 7.4) by centrifugation at 1600 rpm for 15 minutes 
and were finally resuspended in 15 mL of the PBS solution. A cell count was then performed 
using a light microscope and hematocytometer to determine the final cell density in the PBS 
solution. K562, a BLCL and Jurkat cell lines were also cultured over a period of one week in 
RPMI with 10% fetal bovine serum (FBS). The cells were isolated from the culture medium by 
centrifugation, repeated washing (as described previously) and finally resuspension in 1X PBS. 
A light microscope and hematocytometer was used to determine the final cell densities in PBS.  
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In this study, the white blood cells suspended in PBS solution were scanned within a 
potential range of -0.5V to 1.2V at a scan rate of 100mV/s. The white blood samples were 
acquired from 5 human subjects and the cyclic voltammetry studies conducted over the course of 
several days. A new carbon fiber electrode was used for each sample. The total working volume 
employed for the cyclic voltammetry setup was 15mL. The white blood cells were activated by 
addition of 1 μL each of phorbol-12-myristate-13-acetate (PMA) and ionomycin per 1mL of the 
total working volume to achieve final concentrations of 5ng/ml and 500ng/ml, respectively. The 
effect of variable glucose concentrations was investigated. The peak potentials and currents 
associated with the observed oxidation peaks were determined using MATLAB® software. 
Any oxidation peaks present in the cyclic voltammograms were identified and the electric 
potential range for the region of interest corresponding to the oxidation peak defined. Upper and 
lower boundaries corresponding to the region of interest were determined by visual inspection to 
identify the highest and lowest electric potentials corresponding to the width of the identified 
oxidation peak. Linear regression and interpolation was then used to fit a baseline bounded by 
the two points corresponding to these upper and lower potentials. The interpolated current values 
for the baseline were subtracted from the original current values of the cyclic voltammogram 
within the region of interest corresponding to the oxidation peak. As a result, adjusted values for 
the peak current were obtained.    
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6.3.2 Microdialysis and High Performance Liquid Chromatography 
In vitro microdialysis [76] was used in these experiments to extract the released biochemical 
content from the cell suspension, while high performance liquid chromatography (HPLC) with 
electrochemical detection was subsequently used to validate whether or not serotonin was 
released by the cells, as well as to quantify the amount of serotonin released upon cell activation. 
The microdialysis probe is constructed from 23-gauge stainless steel tubing, with a hollow fiber 
that runs through the length of the tubing (Figure 28). A small length of the hollow fiber (approx 
1.5-2.0mm) is allowed to protrude from the end of the stainless steel tube and remains in contact 
with the surrounding solution. Within the hollow fiber is vitreous silicate tubing. This silicate 
tubing serves as an inlet section for perfusing buffer, while the outlet section is housed in the 23-
G steel tubing. Since the cells are suspended in PBS, a PBS buffer solution can also be used for 
perfusion. HPLC can be used to identify and quantify biochemicals in solution. It comprises a 
column containing the stationary phase and an injector used to introduce the mobile phase 
containing the dissolved species of interest into the column. If the mobile phase contains a 
mixture of chemicals, separation of the chemicals occurs using this chromatography technique 
due to their variable solubilities. Retention time is important. If the chemical is more soluble in 
the stationary phase, it is going to remain in the column longer (longer retention time) than 
another chemical that is more soluble in the mobile phase. An electrochemical detector outputs a 
signal that provides information related to the quantity detected as well as the retention time 
(used to identify the species).  
Approximately 12ml of whole human blood was obtained from healthy volunteers and the 
white blood cells isolated on a Ficoll-Paque™ gradient (as described previously). The cell 
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samples were placed on ice for later microdialysis and HPLC analysis. Cells derived from K562, 
Jurkat and BLCL cell lines were also analyzed in order to determine whether 5-HT is normally 
released from these cells. 
1.5mL samples of each of the cell suspensions were placed in microcentrifuge tubes. The 
hollow fiber to be used for microdialysis was allowed to sit in fresh distilled water (dH2O) for an 
extended period of time. For cell stimulation, PMA and ionomycin are introduced and 20-30 
minutes allowed for complete activation. Microdialysis was used to isolate 5-HT released by the 
cells. 3 samples were collected from microdialysis of the cell suspensions and controls (perfusion 
rate of 5uL/min for 2 minutes) in autosampler tubes. The hollow fiber of the microdialysis probe 
was made about 1 cm long to improve the rate of recovery. Percent recovery was determined 
from the standard solution. HPLC was used to analyze the following samples: 
a. PBS 
b. PBS + PMA (5ng/ml) + ionomycin (500ng/ml) 
c. PBS + PMA + ionomycin + glucose (1mg/1ml) 
d. Non-activated PBMCs and cell lines 
e. Activated isolated PBMCs and cell lines 
f. Non-activated PBMCs and cell lines with D-(+)-glucose (1mg/1ml) 
g. Activated PBMCs and cell lines with D-(+)-glucose (1mg/1ml) 
h. Blood plasma 
 
 
For washing, the hollow fiber was placed in dH2O and allowed to dialyze at a rate of 
20ul/min for 2 minutes. It was then placed in fresh dH2O for 3 minutes between samples to wash 
out any residual 5-HT.  8.2uL sample volumes were injected into the HPLC by a FAMOS 
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autosampler. Detection of any 5-HT was determined electrochemically using an Antec-Leyden 
Intro amperometric detector (Zoeterwoude, The Netherlands).  
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Figure 28: In-vitro Microdialysis 
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6.4 RESULTS AND DISCUSSION 
6.4.1 Cyclic Voltammetry 
Cyclic voltammetry of PBMCs, K562, Jurkat and BLCL 
Cyclic voltammograms acquired from isolated human PBMCs suspended in 1X PBS and 
activated with PMA (5ng/ml) and ionomycin (500ng/ml) revealed oxidation peaks at an average 
potential of 368mV (+/- 18mV) vs. SCE. Peak currents up to 12 µA within the 350mV to 400mV 
range were recorded for cell densities on the order of 106 cells/ml (Figure 29 and Figure 30). 
Oxidation peaks were not observed for any cultured cell type, i.e. for the K562, Jurkat and BLCL 
cells. There was a noticeable absence of a reduction peak in the voltammograms, which normally 
implies that irreversible oxidation of the species has occurred. Peaks were neither observed in the 
absence of cells nor before activation of the cells with PMA. The results of our experiments 
strongly suggest that the activated lymphocyte-monocyte mixture comprising the PBMCs 
releases redox active species into the extracellular environment upon activation. Based on studies 
performed by previous research groups (see Table 5), it is likely that the redox species 
responsible for the 368mV oxidation peak is 5-HT [72-74]. It has been suggested that 5-HT is 
released from certain human leukocytes during inflammatory responses, particularly in response 
to allergens during allergic reaction.  In the literature, the oxidation peak for 5-HT was normally 
reported at around 330 mV vs. SCE, which is a slightly lower value than what we have recorded 
in our own studies [73]. The absence of a reduction peak was often noted, and has been 
attributed to the irreversible oxidation of serotonin (5-HT) to 5-hydroxyindoleacetic acid (5-
HIAA) [77].  
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The oxidation peaks obtained from the cell suspensions were barely discernable against 
the background currents, as the total area bounded by each CV curve was very large by 
comparison to the area bounded by the oxidation peaks within the 350mV to 400mV range 
(Figure 29). The large background currents are a direct consequence of two factors, namely the 
scan rate (set at 100mV/s) and the large surface area of the carbon felt electrodes. The larger the 
surface area of the electrode, the larger the electrode’s capacitance. The relationship between the 
scan rate, capacitance and peak current can be expressed by the following equation:  
 
1 
 
)]/exp(1[ dsd CRtvCi −−=
where i is current, v is the scan rate, Cd is the capacitance of the electrode, t is time and Rs 
is solution resistance [78]. The peak current for an irreversible reaction is described by the 
following equation: 
 
2/1*2/12/32/15 )1099.2( vCADnxi OOp α=  2  
 
where ip is peak current, α is the electron transfer coefficient, n is the number of electrons 
transferred, A is surface area, Do is the diffusion coefficient, Co* is the concentration of the 
species in the bulk solution and v is the scan rate [78].  
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Differences between the results of our own studies and those of other researchers 
A reason for the obvious difference between the peak potentials reported in the literature and our 
own is not immediately apparent. The 30mV difference may not be significant, since slight 
changes in the electrode surface can significantly impact peak potential. However, a possible 
explanation may be found in the difference in techniques used to define the location of the peak. 
Another possible explanation may be related to differences in the diffusional effects associated 
with serotonin transport to the electrode surface.  It was observed that for the first three PBMC 
samples, there appeared to be a good correlation between the cell density and the magnitude of 
the peak current (Figure 31). For the fourth and fifth samples, however, the magnitude of each of 
the peak currents recorded was significantly lower than expected. In the case of one of the 
samples (Sample 4), a peak was not observed at all, despite activation with PMA and ionomycin. 
We have not been able to conclusively determine why an oxidation peak was not observed in this 
instance. However, one reasonable explanation may include the possibility that the PBMCs are 
not solely responsible for the observed currents, but that some other cell type is involved. During 
the isolation process on the Ficoll-Paque gradient, the PBMC layer extracted may have been 
contaminated with other cell types, including polymorphonuclear leukocytes (PML), such as 
neutrophils, leading to the observation of oxidation peaks associated with 5-HT release in the 
first three subjects. One study published by Nakamura et al. [73] reported that oxidation peaks 
associated with 5-HT release were only observed for isolated neutrophils and not for the isolated 
lymphocyte-monocyte mixture. In the fourth and fifth subjects, the neutrophil content may have 
been significantly less than the previous three subjects, resulting in much lower oxidation peak 
currents than expected. It should be noted that the experiments were performed on five separate 
days, with the electrochemical analysis of each cell performed on separate days. It was ensured, 
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however, that the techniques used to isolate the cells and to study them remained relatively 
unchanged. The theory that contamination by PMLs has occurred is, however, unlikely since 
centrifugation of blood on a Ficoll gradient would result in a well defined layer of erythrocytes 
containing PMLs such as neutrophils, basophils and eosinophils at the very bottom of the tube. 
PBMCs form a very well-defined layer at the top of the Ficoll gradient that can easily be 
extracted without contamination from other layers.  
 
Establishing a relationship between the oxidation peak and glucose metabolism 
An attempt was also made to verify whether or not the peaks were directly associated with 
glucose metabolism, as this may be an alternate source of oxidation current. It is well known that 
several types of cells contain protein complexes in their cell membranes that function as electron 
transport chains. The NADPH oxidase complex, for example, comprises structures within the 
plasma membrane that upon association in an activated state transfer electrons between the 
pentose phosphate pathway of glucose metabolism and extracellular oxygen. Many white blood 
cells, particularly human PMLs (neutrophils [57],[55] and eosinophils [56],[54]), express this 
enzyme complex. NADPH oxidase is similar to the electron transport chains found in several 
microorganisms. Previous research performed by other authors demonstrated that increasing the 
concentration of metabolizable fuels in bacterial cell cultures is associated with decreasing peak 
current in their cyclic voltammograms. It is known that a number of microorganisms can transfer 
electrons to electrodes by several mechanisms, including: i) the use of artificial electron 
mediators (electronophores) such as neutral red; ii) using mediators produced by the 
microorganisms themselves; iii) direct electron transfer across the bacterial cell membrane [33]. 
In one study by Prasad et al., the direct electron transfer ability of yeast cells, Hansenula 
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anomala, was demonstrated by cyclic voltammetry [36]. In the study, the authors reported 
oxidation peaks at 0.09V and 0.38V. Several additions of lactate stock resulted in a decrease in 
the magnitude of the peak currents. The explanation provided was that when nutrients such as 
lactate or glucose are introduced to the cells, the peak currents decrease indicating that direct 
electrical communication exists with the electrode. Electroactive enzymes in the extracellular 
membrane of the cells accept electrons generated through the oxidation of the fuel and are 
subsequently reduced. The reduced enzymes then transfer electrons to the electrode becoming 
oxidized themselves. The smaller peak currents reflect the fact that the majority of the enzyme 
population is unavailable due to their reduction resulting from increased rates of lactate 
metabolism.  
In our study, addition of glucose to the WBC samples, however, was not normally 
associated with a clear decrease in the peak current. In most cases, addition of glucose did not 
appear to be correlated with the peak current at all (Figure 32). In a further investigation of 
Sample 5, however, a clear decrease was observed over the course of several successive CV 
cycles (sequence of 15 CV cycles) in spite of the addition of glucose to the cell suspension 
(Figure 33). The variability in the peak currents observed in Figure 32 reflects a possible role of 
mass transport to the electrode surface. In the event that inadequate mass transport occurs (such 
as when there is insufficient stirring of the sample solution), peak currents may be smaller than 
expected for certain cyclic voltammograms due to a lack of the reduced species at the electrode 
surface. These results suggest that the oxidation peak is due to a species that has been released by 
the cells into the extracellular environment. Irreversible oxidation of 5-HT to 5-HIAA is the most 
likely reaction.  
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Extracting the oxidation peak current 
One problem that was encountered while conducting the CV studies was a rather unstable i-V 
curve for the cell suspensions. The overall shape of the CV curves and the absolute values of the 
current magnitude tended to differ appreciably from cycle to cycle for the same sample. 
Therefore, a control curve (obtained from performing CV on a non-activated cell population) 
often did not provide an appropriate overlap (background current-voltage curves) that could have 
been used to subtract from the experimental case to obtain the true peak current value. Instead of 
relying on this background current, MatLab was used to create a linear baseline fit within the 
potential range corresponding to the width of the peak (Figure 30). The boundary points of the 
peak, however, were determined solely by visual inspection and consequently there is an 
associated error that should be considered. This error, however, does not exceed a potential range 
of approximately +/- 10mV at each boundary point, and thus +/- 20mV for the entire width of the 
peak. The magnitude of the peak current was obtained by subtracting the original experimental 
values of the peak, from the current values that lay along the baseline fit that was previously 
established. Due to the fact that visual inspection was required in order to identify the boundary 
points of the peak current and to create the baseline current, errors may be expected in terms of 
the peak potential. Notable, however, was the fact that the average peak potential appeared to 
increase with increasing average cell density (Table 6). One thing that should be taken into 
consideration is the fact that the greater the cell density, the more viscous the cell suspension 
becomes. Therefore, it is more than likely that the peak potential becomes higher with increasing 
cell density due to the greater diffusion effects that accompany the changing fluid viscosity. 
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Cyclic voltammetry of 5-HT samples 
Cyclic voltammetry of samples of 5-HT dissolved in PBS revealed oxidation peaks at about 
400mV. The peak potentials were evidently slightly higher than that observed for the WBC 
samples. However, there were very similar characteristics, in that an oxidation peak was 
observed with the absence of a corresponding reduction peak. On successive cycles (2nd and 3rd 
CV cycles), the height of the peak decreased by more than 50%, indicating that i) there is less 5-
HT available in the solution for oxidation and ii) that electrode filming might have occurred, a 
very common problem associated with carbon-based electrodes. In Figure 29, peaks were not 
observed in the 2nd, 3rd and subsequent cycles. Since only a very small quantity of 5-HT would 
be expected to be released by the cells, it is more than likely that the sensitivity of the Gamry 
was not sufficient to detect the smaller concentrations subsequent to the initial cycle. By varying 
5-HT concentrations and measuring the peak currents from the cyclic voltammograms, a direct 
proportionality relationship was established between 5-HT concentration and peak current 
(Figure 34).  Addition of glucose to the 5-HT solution did not affect the decreasing trend of the 
peak current significantly. There was some variation in the measurements made of peak current 
with addition of glucose, but over time (or over successive CV cycles) there was a clear decrease 
in the peak current.  
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Figure 29: i-E (or I-V) curves (5 cycles are shown) from the cyclic voltammetry of activated human 
lymphocytes. Two peaks can be perceived at about 400mV and 750mV. The first peak is due to serotonin 
released by the cells in their activated state. The second has been reported in the literature to be associated 
with CoA in the extracellular membrane. 
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Figure 30: Oxidation peak at around 400mV vs. SCE was identified. An approximation to the current 
amplitude of the observed peak was determined by creating a linear baseline fit spanning the width of the 
oxidation peak. The boundary points corresponding to the width of the peak were identified by visual 
inspection and the linear regression and interpolation performed using MatLab software. Subtraction of the 
baseline from the actual cyclic voltammogram current values gave an approximation of the current 
amplitude of the oxidation peak. 
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Figure 31: Variation in the amplitude of the oxidation peak current is plotted with PBMC density for 
blood samples acquired from five different individuals. Each sample was studied using a fresh carbon fiber 
electrode and conducted over the course of several days. Inspite of the large number of cells present in 
Sample 4, oxidation peaks were not detected for the activated lymphocytes. This may indicate an absence of 
cells that serve as the major contributor to the peak current. If the currents are produced by the lymphocyte-
monocyte mixture, the lower than expected currents for Samples 4 and 5 may indicate failure of the cells to 
activate. 
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Table 5: Summary of previous cyclic voltammetry studies of white blood cells acquired from human 
beings, as well as from various other animals. All measurements were made in PBS with a saturated calomel 
electrode (SCE) as the reference electrode. 
 
 
Article Cells Working 
electrode 
Ep Ip Electroactive species 
Ci et al. (1998) White rabbit 
leukocytes and 
erythrocytes 
Graphite 0.32V 
(leukocytes) 
0.73V 
(erythrocytes) 
1μA per 105 
cells for Ep = 
0.32V 
Membrane-bound 
proteins? 
Matsunaga et al. 
(1989) 
Rat basophilic 
leukemia cells 
(RBL-1) and 
mouse 
lymphocytes 
Basal plane 
pyrolytic 
graphite 
0.34V and 0.68V 
(RBL-1) 
0.65V (mouse 
lymphocytes) 
0.76μA per 105 
cells for Ep = 
0.34V 
Serotonin (0.29-0.34V) 
CoA (0.65-0.74V for 
microorganisms) 
Nakamura et al. 
(1991) 
Human 
leucocytes 
Basal plane 
pyrolytic 
graphite 
0.33V and 0.68V 
(leucocytes) and 
0.68V 
(erythrocytes) 
0.36-0.58 μA 
per 106 cells for 
Ep = 0.33V 
Serotonin (0.29-0.34V) 
CoA (0.65-0.74V for 
microorganisms) 
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Figure 32: The relationship between glucose concentration and the peak current magnitude is 
explored for four white blood cell samples suspended in PBS (PBMC Samples 1, 2, 3 and 5). A consistent 
increase in peak current with glucose concentration was observed only for Sample 3. A correlation could not 
be established for the other 3 samples. These results imply that there is little to no correlation between glucose 
metabolism and the oxidation peak observed from the cyclic voltammograms. As a result, a possible role of 
NADPH oxidase or any other membrane-bound proteins as a direct source of electrons is eliminated. 
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Figure 33: In spite of the addition of glucose to the PBMC sample (Sample 5), there was a continual 
decrease in the peak current with each successive CV cycle. The sequence number on the x-axis indicates the 
total number of CV cycles performed (16 cycles) in succession. After running 5 cycles, the conditions were 
changed by addition of glucose, in an attempt to determine whether or not a correlation can be made between 
metabolism and the observed oxidation peaks. The decreasing peak current is most likely a reflection of 
decreasing availability of 5-HT in the solution (due to irreversibility of the oxidation reaction). 
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Table 6: Peak potentials for PBMC samples. Sample 4 excluded since no peak was detected. 
 
 
 
365 +/- 8 110 5 
360 +/- 9 49 +/- 1 3 
367 +/- 11 94 +/- 8 2 
379 +/- 7 126 +/- 11 1 
Peak Potential, mV Cell density 
(x104), cell/mL 
Sample 
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Figure 34: (Top) Cylic voltammogram of 5-HT in 1X PBS. (Bottom) Relationship between peak 
oxidation current and serotonin concentration. 
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Figure 35: Decreasing oxidation peak current of 5-HT over time with addition of varying glucose 
concentrations. 
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6.4.2 Microdialysis and HPLC 
HPLC was used to confirm the release of serotonin from the PBMC population. Any 5-
HT present was first extracted from the WBC suspension by microdialysis (Figure 28). The 
HPLC results confirmed that 5-HT was in fact released only from PMA activated white blood 
cells, specifically PBMCs (Figure 36). The cells also did not require physiological glucose 
concentration in order to initiate release. These results go hand in hand with the previously 
performed cyclic voltammetry studies, as they indicate increased extracellular 5-HT concomitant 
with the observed oxidation peaks in the cyclic voltammograms. The HPLC results also 
indicated that 5-HT was not released from the BLCL, K562 or Jurkat cells.      
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Sample Sample Number 
PBS, PMA, Ionomycin 1-3
PBS, glucose, PMA, Ionomycin 4-6
PMA Activated PBMCs 7-9
PMA Activated PBMCs + glucose 10-12
Blood plasma 13-15
 
Figure 36: Peak areas corresponding to the electrochemical detection of 5-HT released by human 
PBMCs. 5-HT release was associated with activation of the PBMCs with PMA and ionomycin. HPLC of PBS 
and blood plasma reveals baseline peak area values. 
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6.4.3 Comparison with literature results 
The observation of oxidation peaks and positive HPLC results corresponding to 5-HT in 
our studies with human lymphocytes and monocytes disagrees with the results from previous 
work performed by Nakamura et al. (1991) [73] on human neutrophils and human lymphocyte-
monocyte mixtures. In their study, the authors reported that oxidation peak currents were not 
obtained from the lymphocyte-monocyte mixture. However, peaks were observed for the isolated 
neutrophil population. Our own studies indicate otherwise. Upon activation of the lymphocyte-
monocyte suspension with PMA and ionomycin, there were discernable oxidation peaks at 
around 368mV vs. SCE. There were, however, differences in the implementation of the two 
studies. In our study, a phorbol ester was used to activate the cells, which had been suspended in 
PBS. Carbon felt was used as the working electrode. In the study by Nakamura et al., however, a 
basal pyrolytic graphite electrode was employed with the leucocytes attached to the electrode 
surface through immobilization on a porous nitrocellulose membrane filter. The authors did not 
use a phorbol ester, but rather applied known allergens to the blood samples before performing 
CV. The allergen was expected to induce an allergic response by the cells, resulting in the release 
of various compounds normally associated with cell activation. The difference between our 
results and theirs cannot be explained at the present time. The variable conditions between the 
two experiments may play a significant, but as yet, unclear role and one can only surmise at the 
moment. Another possibility for the observation of peak currents in our experiments is that the 
PBMCs contained some neutrophil content that would have accounted for the majority of the 
serotonin released. As seen in Figure 31, the cyclic voltammogram of PBMC Sample 4 did not 
demonstrate an oxidation peak, despite the high cell density at which the lymphocyte-monocyte 
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mixture was suspended. Smaller peaks than expected were also evident for the PBMC Sample 5 
acquired from a different subject. Two possible explanations are that the cells from Samples 4 
and 5 were not sufficiently activated or that there was a significant lack of neutrophils that might 
have contaminated the first three PBMC samples but was not present in sufficiently large 
numbers in the last two samples obtained.  
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6.5 CONCLUSIONS 
This work builds upon work performed by previous authors demonstrating that serotonin 
release from human white blood cells can be detected using electrochemical techniques such as 
cyclic voltammetry. Previous work by other researchers has similarly been performed for white 
blood cells isolated from rodents and white rabbits. In these studies, peaks were also reported 
within the 300 to 400mV range; however, in one study the oxidation peak was attributed to 
serotonin, while in the other study, the peak was attributed to electroactive membrane-bound 
proteins. In this study, it was shown that human lymphocyte-monocyte mixtures (PBMCs) 
isolated from whole human blood on a Ficoll gradient release serotonin upon activation with a 
phorbol ester, namely PMA, and calcium ionomycin. Identification of serotonin was verified by 
HPLC with electrochemical detection. Well-defined peaks were observed on HPLC 
chromatograms, which was a clear indication of the presence of serotonin in the injected 
samples. In previous studies, activation of the white blood cells was normally achieved by 
application of allergens. In order to refute the theory that the peak was due to direct electrical 
communication between the cells and the electrode surface through membrane-bound proteins, 
various quantities of glucose were added to the WBC suspension and cyclic voltammograms 
subsequently obtained. According to work performed by other research groups such as Prasad et 
al., addition of a metabolizable biofuel, such as lactate or glucose, should decrease the height of 
the peak current if the peak is in fact due to direct electrical communication between cellular 
metabolism and the electrode. Tremendous variation was observed for the height of the peak 
current with the increasing glucose concentration. A clear decrease was not apparent from the 
four PBMC samples that demonstrated oxidation peaks. In fact, a decrease in the oxidation peak 
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height would normally be expected, since 5-HT is irreversibly oxidized to 5-HIAA. The 
variation observed in most of the samples; however, appear to be indicative of diffusion limiting 
effects, associated with the mass transport of the electrochemically active species to the electrode 
surface. Insufficient stirring of the solution and/or time dependent release of serotonin quantities 
from intracellular stores would be likely contributors to the variation in the peak height, which 
offers a direct indication of the concentration of the species in the bulk solution. Noteworthy was 
the fact that oxidation peaks were not observed for BLCL, Jurkat or K562, despite activation 
with the phorbol ester. The absence of oxidation peaks from the cyclic voltammograms of these 
cells suggests that 5-HT (derived from the amino acid tryptophan) is not a normal metabolic 
product. The majority of the 5-HT released by the white blood cells might have actually been 
absorbed and subsequently compartmentalized by the cells for later release. These results are 
also suggestive of 5-HT as a possible source of electrons in the previous leukocyte-based biofuel 
cell experiments.  
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7.0 SUMMARY AND FUTURE WORK 
Research project goals 
The primary goal of this research was to explore a possibly novel method for generating 
electricity within the physiological environment for low power implantable medical devices, 
such as miniature biosensors. Several technologies have previously been developed to power 
larger implantable devices such as cardiac pacemakers and deep brain stimulators [2, 15]. The 
power densities required for these devices are rather significant, and as a result high capacity 
energy sources such as lithium ion batteries have been commonly employed [5, 15, 17]. 
Throughout the literature, many research groups have explored other potential power sources to 
replace internal batteries, due to the problem of size (batteries are rather bulky) and limited 
lifespan (lithium ion batteries can last for up to 10 years, however, a longer lasting power source 
may eliminate the need for surgical explantation). Apart from the various modalities explored for 
transcutaneous energy delivery, other devices such as nuclear devices, piezoelectric devices [8, 
9, 18] and implantable biochemical/biofuel cells [3] have been studied. Nuclear batteries have 
achieved incomparable success from a technical standpoint [6, 7], however, regulatory issues 
quickly stunted their wider employment in the medical device field. Piezoelectric devices have 
been plagued by their very low current and power densities, until very recently [18]. Biofuel 
cells have also been achieving a reasonable amount of recognition as potential power sources, 
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particularly since the development of an enzyme-based biofuel cell for continuous glucose 
monitoring and of another enzyme-based BFC that runs on alcohol for powering small, portable 
devices. As our group became more knowledgeable about the theories (thermodynamic and 
kinetic) that govern electrochemical devices such as biofuel cells, it became more evident that 
the challenge of powering implantable stimulating devices, including pacemakers, would be 
difficult to overcome. We have, therefore, attempted to focus our attention increasingly on the 
novel fields of micro and nano-technology, which are creating unique opportunities for the 
development of small, minimally invasive biosensors for the detection of pathologies such as 
cancer. For such biosensors, small amounts of power may be needed for detection, as well as for 
communication with extracorporeal devices.  Biofuel cells appear to be promising, due to the fact 
that they are essentially biomimetic devices that generate electricity in a similar manner to the 
way that cells generate energy through respiration. A biofuel cell can transduce the energy stored 
in various organic substrates such as glucose into electricity, by coupling the oxidation of the 
fuel with the reduction of the essential universal biological electron acceptor, oxygen.  
 
Electron transport between biological species and electrodes: Challenges 
Electron transfer between biological species and electrodes remains a challenging problem, but 
not an insurmountable one.  In this work, we have actively sought to determine the feasibility of 
developing a novel type of biofuel cell, one that is based on electron transfer between human 
white blood cells and an electrode surface. A significant amount of research performed by other 
groups has previously focused on microbial [40] and enzyme [49] based biofuel cells that 
generate electricity through the catabolism of organic substrates such as glucose. Our studies 
described here are a unique contribution to the field in that these were the first to suggest and 
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attempt to employ whole eukaryotic, and more specifically, human white blood cells to generate 
electricity through electrochemical interactions with the anode of a biofuel cell. The unique 
concept that we presented was that NADPH oxidase, a plasma membrane based enzyme complex 
expressed extensively among phagocytic white blood cells, can self-mediate electron transfer 
between intracellular NADPH and an extracellular electrode. The hypothesis stemmed from the 
many studies that indicated certain microbes, such as those belonging to the metal reducing 
Geobacter family, are capable of self-mediating electron transfer to metals and metal electrodes 
due to the presence of an electron transport chain proteins in their outermost membrane [30]. 
Electron transport is typically not characteristic of the plasma (extracellular) membranes of 
eukaryotic cells in general. It is an important aspect, however, of glucose metabolism in the 
mitochondria. Prokaryotic organisms such as bacteria, unlike eukaryotic cells, do not possess 
mitochondria; neither do they possess any other organelles typically found in the cells of 
eukaryotes [69]. Glucose metabolism in its entirety occurs within the intracellular environment 
of prokaryotes and the final electron transport process is characteristic of the extracellular 
membranes of microbial organisms.    
A number of microbes have been shown to be capable of self-mediating electron transfer 
to electrodes. Various mechanisms for electron transfer have been proposed, including indirect 
electron transfer through mediators excreted by the cell and direct electron transfer through 
membrane bound electron transport proteins associated with metabolism. The latter has 
commonly been considered as a very likely mechanism in the literature. Normally, electron 
transfer through the direct method described previously occurs at very low efficiencies, and as a 
result artificial electron mediators (or electronophores) are commonly employed to improve the 
electron transfer efficiency. This low electron transfer efficiency is an extremely important 
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problem to consider, as this explains the very low currents observed from microbial fuel cells 
that did not employ artificial electron mediators (such as methylene blue and neutral red) and 
also is a more than probable explanation for the very low currents observed from our own biofuel 
cell studies with white blood cells.  
The issue of low electron transfer efficiencies is a fundamental difficulty that faces 
bioelectronic systems [53]. Low currents obtained from bioelectronic systems are largely 
associated with i) the distance between the electron donor and acceptor (rate of electron transfer 
decreases exponentially with distance), ii) the aqueous environment characteristic of many 
electrochemical systems and iii) inaccessibility of redox active centers – embedded within the 
three dimensional protein structures - to the electrode surfaces [53]. The low currents that we 
have reported for our biofuel cells is likely a consequence of the inability of the carbon fiber 
electrodes to achieve good electrical communication with the redox centers of the NADPH 
oxidase enzyme complex. Cytochrome b558 contains the redox active center of NADPH oxidase 
that is normally responsible for transferring electrons to the final electron acceptor, molecular 
oxygen [58]. Now, consider the structure and characteristics of molecular oxygen. It is small, 
mobile and interacts in a very specific orientation with cytochrome b558. These are 
characteristics that a carbon fiber electrode can rarely, if ever, compete with without 
modification. In the context of a biofuel cell, where the white blood cells are in suspension 
around the carbon fiber electrode and may even attach to the electrode, many electrons derived 
from intracellular NADPH are likely to be preferentially transferred to oxygen in the surrounding 
solution, rather than to the electrode. This is a very important problem that must carefully be 
considered in our current study. Bacteria such as Escherichia Coli are capable of producing 
comparatively larger currents than our own fuel cell because they 1) can survive in an anaerobic 
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environment (nitrogen gas is often passed through the anode compartment to remove any 
dissolved oxygen that may interfere with the electron transfer process to the electrode) and 2) 
artificial electron mediators may be employed as a means of bridging the gap between the 
metabolic processes of the cells and the electrode. Neither of these techniques can be applied to 
white blood cells primarily because 1) cells can only function anaerobically for a short period of 
time and therefore will always require oxygen for mitochondrial glucose metabolism and 2) 
many electron mediators can be toxic, which is undesirable for any in-vivo human applications. 
Depriving cells of oxygen would quickly lead to cell death as oxidative phosphorylation in the 
mitochondria would cease. Maintaining sufficient quantities of oxygen in the extracellular 
environment would mean that electrons from the pentose phosphate pathway – the primary 
source of NADPH – would ultimately be preferentially transferred to the smaller, more mobile 
oxygen molecules. The situation can essentially be regarded as a double-edged sword. In order to 
attain higher electron transfer efficiencies, an artificial electron mediator would become 
absolutely necessary.  Employing an artificial electron mediator on the other hand may lead to 
detrimental effects to the biological system.  
 
Improving the efficiency of electron transfer 
Earlier in this work, it was reported that several techniques had previously been employed by 
other groups to improve the electron transfer efficiency between bacteria and electrodes. Apart 
from simply introducing free roaming mediators in the anode compartment of the BFC, the 
mediators were immobilized to the electrode. In studies by Park et al. [79], neutral red was the 
electron mediator of choice and was immobilized onto carbon-based electrodes. Immobilization 
of the electron mediators was not the only method used. In many studies, attempts were made to 
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immobilize the bacteria themselves to the electrode surface. Biofilms were applied to the 
electrode surface, allowing the growth of bacterial colonies that could survive and thrive by 
transferring the electrons derived from the metabolism of various substrates. Special permeable 
membranes could be used to keep the biofilm against the electrode, but still allowing nutrients to 
traverse their structure. Although this technique could achieve a reasonable amount of success 
with bacteria, the same would be impossible for white blood cells. The idea that we are pursuing 
for an implantable biofuel cell would be one that could be placed within the physiological 
environment, without the need for any specific attachment of cells to the surface, a process that 
would be a very difficult problem to overcome. The goal would be to do very little to disrupt the 
physiological environment, but to still encourage good electrical communication with the cells in 
close proximity to the BFC electrode. Attachment of cells to the electrode surface would not be 
beneficial since the cells multiply and are eventually replaced by daughter cells. The BFC 
should, therefore, be capable of interacting with any cells in its immediate environment and of 
producing electricity, irrespective of the dynamic conditions within which it is placed.  
Schroeder et al. also recognized the low electron transfer efficiency problem facing 
microbial fuel cells and formulated their own perspectives and implementation in tackling the 
issue [40]. Carbon-based electrodes modified with a platinum black overlay and electrically 
conducting polymers were employed in a microbial fuel cell with Escherichia Coli. Glucose was 
used as the fuel. At the time of their publication, Schroeder and co-authors reported the highest 
current and power densities ever attained by a microbial fuel cell. The specific conducting 
polymer used was polyaniline. The use of conducting polymers is an interesting and potentially 
promising concept that could be applied to solving a number of problems with respect to biofuel 
cell technologies for implantation within the body. Electrodes could be modified with 
 122 
  
electrochemically deposited conductive polymers (PEDOT, polyaniline and polypyrrole) to 
promote good cell adhesion and improved cell to electrode electron transfer. The presence of the 
conducting polymers also makes it possible to incorporate bioactive molecules to promote good 
biocompatibility and reduce scar tissue formation around the implant. This has been shown in 
studies by Wadhwa et al., where dexamethasone (a drug shown to effectively reduce glial scar 
formation in the brain) was incorporated into an electrode containing polypyrrole – a well-known 
and studied conducting polymer [80]. Upon application of an electric potential to the electrode, 
small quantities of the drug could be released. A similar concept may be applied in the case of 
biofuel cell electrodes, where scar tissue formation could effectively be halted with the release of 
bioactive drugs from the electrode surface during the biofuel cell’s operation. In the original 
study by Schroeder et al., it was noted that the higher current densities may have been due to 
ability of the conducting polymer chains to access the redox active centers embedded within the 
proteins of the cell membrane. In spite of the possible improved electrical interactions, however, 
between the electrodes and the cells, other factors may have played just as significant a role in 
the authors attaining such high current and power densities. One of those factors is that an 
anaerobic atmosphere was maintained at the anode during the biofuel cell operations. The 
presence of oxygen at the anode may have still been a very prominent problem. The other factor 
was that electric potential pulses on the order of 1V were periodically applied to the electrode 
surface. The potential pulses were applied in order to remove adsorbed species from the 
electrode surface that could contribute to electrode fouling, hence reducing the electron transfer 
efficiency, rates and overall current and power. Electrode fouling can be a significant problem 
for biofuel cells, due to the presence of several proteins and other species that could adhere to the 
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electrode surface, particularly to surfaces that are carbon based, which tend to be rather 
hydrophobic.   
 
Activation of the NADPH oxidase complex 
Another significant hurdle associated with using the phagocytic white blood cell NADPH 
oxidase as a source of high energy electrons is the fact that the individual components of the 
enzyme associate into their final functional form only during the enzyme’s activated state. The 
purpose of the NADPH oxidase enzyme complex should be kept clearly in mind. As described 
earlier in this work, NADPH oxidase is an important aspect of the host immune or inflammatory 
response. It is responsible for the generation of free oxygen radicals (reactive oxygen species) 
such as superoxide (and consequently hydrogen peroxide). In order to produce the reactive 
oxygen species (ROS) that are used to attack invading organisms, NADPH oxidase must become 
activated after which it can bind molecular oxygen. During this binding, electrons derived from 
the pentose phosphate pathway of glucose metabolism are transferred to NADPH oxidase via the 
coenzyme NADPH and to the final extracellular electron acceptor. Protons of equivalent but 
opposite (positive) charge are simultaneously pumped out of the cell through ion channels in the 
membrane to complete the circuit. The electrons are accepted by the final electron acceptor, 
oxygen, to form the free radical superoxide. In vitro, activation of the NADPH oxidase complex 
is achieved through the application of specific agents, namely the phorbol ester, PMA, and 
calcium ionomycin. Such activating agents cannot be applied in vivo as they can cause non-
specific activation. PMA has been shown to cause malignant tumors in the skin of rodents [81]. 
For our own in vitro studies, the application of PMA and ionomycin complicated our results, 
since either one or both are electrochemically active species. This fact leads to a further difficulty 
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that may be encountered during the electrochemical studies of biological systems. 
Electrochemical cells in general can be regarded as black boxes, since it can prove extremely 
challenging to determine what exactly is occurring in the system. Some insight can be gathered 
from electrochemical techniques such as cyclic voltammetry and electrochemical impedance 
spectroscopy, which are used to investigate the thermodynamics, kinetics and impedance 
characteristics of the system. However, for biological systems, there are so many unknowns, that 
it can prove difficult to even make an educated guess as to the identity of the electrochemical 
processes that might be occurring, which are contributing to any observed currents or electric 
potentials. It is clear that detailed knowledge of the biological system itself is first required in 
order to come to a more complete understanding as to the nature of the electrochemical 
interactions and insight into what might be done to optimize the kinetics and reduce energy 
losses within an associated electrochemical cell.  
 
Technical limitations 
It is clear that alternative techniques must be employed in order to effectively conduct in-vivo 
studies of the electrochemical activities of white blood cells and other human or animal cells. In 
these leukocyte-based biofuel cell studies in particular, techniques, methods and apparatuses that 
were previously used to study microbial fuel cells were employed. Bacteria, however, are very 
different from white blood cells and animal cells in general. An inability to attain cell densities 
much higher than a couple of million cells per cubic centimeter was not feasible, something that 
could easily be achieved for the microbes. Therefore, insufficient cell densities and low 
measuring sensitivities due to instrument limitations may be factors contributing to the very little 
or no currents observed for the leukocyte-based biofuel cells. Another issue with respect to the 
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apparatus was that in order to attain high currents, the fuel and bacteria would have to be passed 
at sufficiently high flow rates across the anode [82]. This would be difficult to achieve for the 
white blood cells, as they are not likely to adhere readily to the electrode surface during the 
anodic fluid flow. Maintenance of physiological levels of glucose was, therefore, difficult to 
achieve in our experiments.  
In order to overcome the previously described challenges, a solution may be to employ 
microfluidics to the study of white blood cell electrochemical activity. Rather than requiring 
larger volumes of the cell suspensions (typically on the order of 10mL in our studies), volumes 
on the order of microliters could be used. An anode with microfluidic channels, such as that 
described by Chiao et al. [43] could be very beneficial to a biofuel cell study with white blood 
cells. With such small volumes, it would become important to utilize instrumentation with very 
high sensitivities for recording current magnitudes.  
 
Biofuel cell design for in vivo applications 
The larger problem associated with the development of biological or biofuel cells for implantable 
medical devices can actually be divided into smaller, yet very important problems. The first 
problem has been highlighted in the several paragraphs that have preceded this one and is 
perhaps the most important. Establishing electrical communication links between biological 
species and electrode surfaces will continue to be a very fundamental and significant problem. 
The other problems actually fall within the realm of design, specifically the design of the 
individual components that make up the physical structure of the biofuel cell. Apart from 
improving the efficiency of electron transfer between biological species (enzymes or whole cell) 
and electrodes, some of the major challenges facing an actual implementation of an implantable 
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biofuel cell also include 1) eliminating the proton exchange membrane (PEM); 2) eliminating the 
ferricyanide solution, while improving the rate of oxygen reduction at the cathode; and 3) 
miniaturization of the device while still maintaining sufficiently high current and power 
densities.  
An in vitro implementation of our biofuel cell currently requires a PEM to separate the 
anode and cathode compartments. The purpose of the PEM is to i) prevent shorting of the current 
through physical contact between the anode and cathode electrodes; ii) separate the anode and 
cathode solutions (the cathode solution, ferricyanide, would be toxic to the cells); iii) selectively 
permit the movement of protons to the cathode, while preventing larger negatively charged ions 
from passing. A Nafion-117 proton exchange membrane was used in our in vitro study. One of 
the issues surrounding the membrane is that it was not designed to be implanted. The other 
problem is the fact that within the context of the physiological environment, it would be 
impossible to use the PEM to separate the anode and cathode reactants, since tissues are largely 
homogenous in their content. To tackle the problem of homogeneity with respect to the reactants 
presented to the electrodes of a biofuel cell, a number of researchers (including the Heller group 
at the University of Texas at Austin) designed electrodes that were modified with enzymes [19-
21, 49, 83]. The enzymes permitted specific reactions to occur at each electrode, namely the 
oxidation of glucose to gluconolactone at the anode and the reduction of oxygen to water at the 
cathode. The PEM as well as the ferricyanide solution (normally employed at the cathode for its 
high redox reversibility and high electron affinity) were made obsolete with this enzyme based 
biofuel cell. Bilirubin oxidase or the laccase enzyme served well to replace the ferricyanide 
solution at the cathode and also prevented the occurrence of fuel crossover, which is problematic 
as it can lead to electric potential losses and kinetic inefficiencies. 
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Possible applications of an in vivo biofuel cell technology 
This novel study of eukaryotic-based biofuel cells has potentially important implications for 
possible future applications of biological fuel cells to powering implantable devices. By adapting 
the fuel cell to operate within a physiologically relevant system, the electrical energy produced 
by the biofuel cell could potentially be used to power an implantable miniature biosensor or a 
microfabricated controlled-release device. In a paper published by Lahann et al. (2003), an 
electrically switchable surface was described [84]. Upon application of an electric potential to 
the surface, dynamic changes in the interfacial surface properties, such as wettability, could be 
achieved. The surface was designed by modification of a Au(111) surface with a self-assembled 
monolayer (SAM). The molecule of choice in this case was (16-Mercapto)hexadecanoic acid 
(MHA). It was explained by the authors that information regarding the potential range required 
for switching of the surface properties could be determined from basic energy considerations. 
Citing previous research, Lahann et al. presented an electrical potential range between -1.046V 
and +654mV vs. SCE (-804mV and 896mV vs NHE), when considering the electrochemical 
stability of alkanethiolates (such as MHA) adsorbed on gold and exposed to solution.  It was also 
estimated that a potential above -118mV vs. SCE (+124mV vs. NHE) would be required to 
satisfy the conditions of molecular reorientation in low density SAMs. Based on these estimates, 
our metabolic biofuel cell would be able to provide a sufficiently large potential to satisfy these 
requirements.   
 
Complexity of bioelectrochemical systems 
Throughout the course of this work, it was difficult to establish an exact mechanism by which 
electron transfer could take place between the isolated white blood cells and the carbon fiber 
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electrodes. Although the release of serotonin from certain white blood cells, specifically PBMCs, 
was verified using cyclic voltammetry and HPLC, the results of the leukocyte-based BFCs 
investigated in this work suggested that some other mechanism might be employed. The PBMCs 
did not appear to generate currents comparable to those observed from the general white blood 
cell population isolated by RBC lysis. This suggests that another type of cell may be involved. 
Oxidation peaks associated with coenzyme A has been previously observed for human white 
blood cells [73]. Since coenzyme A is highly linked to glucose metabolism among eukaryotic 
cells, it is reasonable to consider this species as a likely electron mediator. The evident 
complexity of biological systems as well as electrochemical systems revealed by this research is 
an indication that a lot more work is left to be done in attempting to understand the process of 
electron transfer between biological species and electrodes.    
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APPENDIX A 
LIST OF ABBREVIATIONS 
PML Polymorphonuclear Lymphocyte 
BLCL B Lymphoblastoid Cell Line 
PBMC Peripheral Blood Mononuclear Cell 
CFE Carbon Fiber Electrode 
HPLC High Performance Liquid Chromatography 
CV Cyclic Voltammetry 
WBC White Blood Cell 
BFC Biofuel Cell 
PEM Proton Exchange Membrane 
PEMFC Proton Exchange Membrane Fuel Cell 
MFC Microbial Fuel Cell 
FC Fuel Cell 
MB Methylene Blue 
GOx Glucose oxidase 
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BOD Bilirubin Oxidase 
NR Neutral Red 
PMA Phorbol-12-myristate-13-acetate (activating agent) 
ROS Reactive Oxygen Species 
CGD Chronic Granulomatous Disease 
PPP Pentose Phosphate Pathway 
RPMI Common cell culture media (abbreviation for Roswell 
Park Memorial Institute) 
PBS Phosphate buffered saline 
CoA Coenzyme A 
SCE Saturated Calomel Electrode (common reference 
electrode for electrochemical studies) 
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